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Abstract
Cardiac rehabilitation (CR) is an exercise and education program aimed to help individuals
improve fitness levels to return to their careers and social lives. The dropout rate is high, between
25% to 50%, and is related to several factors with an early predictor being higher anxiety levels.
It is important to understand the patterns and consistency of this variable as it changes
throughout the day and its association physical activity (PA) in order to influence interventions.
Ecological momentary assessment (EMA) and actigraphy can capture momentary anxiety and
PA, respectively, for temporal analysis. This dissertation includes two studies. Study I examined
the error in daily steps of four wearable PA monitors (Fitbit Charge 2, Apple Watch Series 2,
Fitbit Zip, ActiGraph GT9X) in phase II CR patients. Nineteen patients wore activity monitors
on the ankle, non-dominant wrist, and waist on two days that they attended CR and two days
when they did not. Steps from each monitor were compared to criterion steps from the
StepWatch (SW). The Fitbit Charge and Apple Watch captured within 10% of SW steps and
most other monitors underestimated steps. Study II examined the consistency and intra- and
inter-individual patterns in state anxiety (SA) and PA and described the feasibility of mobile
EMA for those in phase II CR. Nine adults received four mobile phone surveys each day,
assessing momentary SA, for 14 consecutive days while concurrently wearing an ActiGraph
GT3X+ across the day. In this study, participants demonstrated consistent, low levels of SA (ICC
= 0.68, average = 9.1 on a scale of 6 to 24). The relationship between PA and SA varied between
individuals, showing positive and negative slopes for individual participants. Survey compliance
rate and ActiGraph wear time met a priori benchmarks for feasibility, but recruitment did not.
Lack of smartphone ownership and limited smartphone access at work were the primary
challenges to recruitment. This study was the first to describe the patterns of momentary SA for
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this population. Individual pattern analysis is necessary for classifying individuals, but further
study is needed to direct development of interventions based on ecologically valid data.

v

Table of Contents
Chapter I: Introduction .......................................................................................................1
References ....................................................................................................................8
Chapter II: Literature Review ............................................................................................16
References ....................................................................................................................51
Chapter III: Step Count Error of Activity Monitors for Patients in Phase II Cardiac
Rehabilitation .......................................................................................................................72
Abstract ........................................................................................................................73
Introduction ..................................................................................................................74
Methods........................................................................................................................75
Results ..........................................................................................................................82
Discussion ....................................................................................................................86
References ....................................................................................................................93
Chapter IV: Using Ecological Momentary Assessment to Explore Anxiety and
Physical Activity for Patients in Phase II Cardiac Rehabilitation ..................................98
Abstract ........................................................................................................................99
Introduction ..................................................................................................................101
Methods........................................................................................................................103
Results ..........................................................................................................................110
Discussion ....................................................................................................................118
References ....................................................................................................................127
Chapter V: Conclusion ........................................................................................................133
Appendices ............................................................................................................................136

vi

Appendix A. Study I Informed Consent ......................................................................137
Appendix B. Study II Informed Consent .....................................................................142
Appendix C. Ecological Momentary Assessment Mobile Survey...............................148
Vita ........................................................................................................................................154

vii

List of Tables
1. Table 1. Summary of participant characteristics........................................................83
2. Table 2. Summary of step data for each monitor and each condition........................84
3. Table 3. Summary of participant characteristics........................................................111

viii

List of Figures
1. Figure 1. Percent of StepWatch steps for each monitor during each condition .........85
2. Figure 2. Percent of StepWatch steps for each monitor during cardiac rehabilitation
sessions ......................................................................................................................87
3. Figure 3. Mean and standard deviation of state anxiety scores across two weeks ....112
4. Figure 4. Three emerging patterns of state anxiety across all survey time points .....113
5. Figure 5. Physical activity as a function of state anxiety score for all participants across
all survey time points .................................................................................................115
6. Figure 6. Physical activity as a function of state anxiety scores inclusive of all nonmissing data points for each participant across all survey time points ......................116

7. Figure 7. Recruitment and enrollment flow chart detailing all new patients, eligible
patients, number who enrolled, and reasons eligible individuals did not enroll ........117

ix

List of Abbreviations
AACVPR
ACCF
AG
AHA
Apple
Charge
CR
CVD
EMA
GT3X+
GT9X
LFE
PA
PAM
STAI
SA
Zip

American Association of Cardiovascular and Pulmonary Rehabilitation
American College of Cardiology Foundation
ActiGraph
American Heart Association
Apple Watch Series 2
Fitbit Charge
Cardiac rehabilitation
Cardiovascular disease
Ecological momentary assessment
ActiGraph GT3X+
ActiGraph GT9X
Low-frequency extension
Physical activity
Physical activity monitor
State Trait Anxiety Inventory
State anxiety
Fitbit Zip

x

Chapter I
Introduction

1

Cardiovascular disease (CVD) is the leading cause of mortality and is the most prevalent
disease in the United States (US) and worldwide (1-3). CVD can refer to several conditions such
as heart failure, valvular issues within the heart, myocardial infarction, arrhythmias,
atherosclerosis, and stroke (4). Individuals living with these conditions or who have experienced
a cardiac event are at increased risk for premature mortality, a secondary cardiac event, other comorbidities, and may experience a reduced quality of life (5). In effort to improve quality of life
and to slow or stop the worsening of their condition, cardiac rehabilitation (CR) is recommended
for patients who have experienced a myocardial infarction, coronary artery bypass graft surgery,
percutaneous coronary intervention, angina, heart transplant, valvular surgery, heart failure, or
peripheral artery disease (4, 6, 7). Although there are many benefits associated with completing
CR (e.g., reduced cardiovascular-related mortality, improved exercise capacity, improved healthrelated quality of life (8, 9)), this program is underutilized with poor referral and adherence rates
(10).
Cardiac rehabilitation is a multi-component, three-phase intervention to help the patient
return to his or her social life and career, reduce the risk of secondary cardiac events, and live a
healthier lifestyle through reducing CVD risk factors (7, 11, 12). Phase I begins in the hospital
setting following cardiac surgical intervention or event. During this phase, the patient progresses
from lying, to sitting, standing, and completing self-care tasks, to allow the safe transition from
the hospital to the patients’ home (4, 6). Following release from the hospital, patients should be
referred to Phase II, which is a 36 session, 6-week outpatient program that includes medically
supervised exercise training, educational classes, and psychological counselling (6). Exercise
prescriptions are designed and implemented by exercise physiologists or cardiac nurses at
outpatient cardiac and pulmonary rehabilitation centers, where the primary goal is to return
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patients to a cardiorespiratory fitness level that will allow them to return to work and their typical
social obligations (4, 6). Educational sessions are offered during phase II to educate patients on
living a healthier lifestyle and psychological counselling is used as needed to reduce anxiety and
depression (13) and aid in the adjustment and acceptance of a CVD diagnosis or change in health
status following a cardiac event (6). Phase II offers support and education during the transitional
time following hospital release, during recovery, through the patients’ re-integration to daily life
and is highly important for improving self-efficacy in continuing behavior changes. Phase III is
the maintenance phase where patients continue exercise either in the outpatient CR setting or in
local fitness centers or community facilities (6).
Benefits of comprehensive CR programs (exercise, education, and psychological
counselling) include improved quality of life, reduced overall disability, decreased risk of
secondary cardiac event, and reduced subsequent hospital visits and healthcare costs (5, 7, 8, 1416). Despite these benefits, the use of CR remains low (17). Independent researchers and
research collaboratives such as the Million Hearts Initiative have been working to address this
and have identified referral, enrollment, attendance, and adherence as for areas for immediate
improvement (10). Systematic level changes like combined automatic referral via electronic
medical records and use of a CR liaison have increased referral rates from 32 to 86% and
increased enrollment rates from 29 to 74% (18). Other factors shown to increase enrollment
between 10 to 20% are home-based CR programs (19), offering flexible hours for CR sessions
(17), and scheduling the first phase II CR session before the patient is discharged from the
hospital (20).
Attendance and adherence are two important considerations for improvement because it
has been demonstrated that patients who attend a greater number of total CR exercise sessions
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have reduced re-hospitalization rates (21) and 5-year mortality rates, with about a 1% reduction
in risk of death per session attended (22). Several strategies for improving attendance and
adherence rates at the system-level are increasing the diversity of educational classes offered
(23), increased group counselling opportunities (as opposed to individual sessions) (23), use of a
video to explain the purpose and importance of CR (24), token (e.g., parking passes, water
bottles, t-shirts) (24) and financial incentives (25) for regular attendance, and women-only CR
exercise sessions (26). However, the very low participation rates (20% to 35% of those
diagnosed with myocardial infarction) and high drop-out rates (40% to 70% within the first 6
months) (5, 27, 28) are not only related to systemic issues, but also have been related to
behavioral factors like anxiety and depression (29, 30).
Anxiety is suggested as the earliest predictor of non-adherence to a CR program (30) and
the exercise portion of CR has been suggested as anxiety-provoking (26). Anxiety is a form of
psychological distress that has two divisions: 1.) state-anxiety, which describes the momentary
feeling of anxiety, characterized as tension, apprehension, nervousness, and worry and 2.) traitanxiety, which is the level one is prone to experience state-anxiety in daily life (31). In two metaanalyses, anxiety (both state and trait) measured by various methods has been shown as a risk
factor for coronary heart disease (32) and slows the recovery following cardiovascular events
(33). Additionally, state-anxiety is commonly experienced amongst those diagnosed with CVD
(34) and individuals with higher state-anxiety scores have been shown to have increased rates of
drop-out from CR (30, 35-37), with some dropping out during the initial assessment period (30).
Anxiety measurements typically occur cross-sectionally in CR, once at the beginning and
then again at the end of the CR program. The early measurement can inform CR nurses of
patients for whom psychological counselling would be necessary (6). Recently, however, it has
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been shown that measures of depression, anxiety, and affect (38-40) fluctuate throughout the
day. These cognitive and emotional factors which were once thought to be stable throughout the
day are a potential source for further explaining in-the-moment decisions for engagement with
health behaviors (41), such as attending CR sessions. Limited research has been completed
investigating the temporal variability of cognitions and emotions, and their effect on health
behaviors. With the understanding that anxiety is a predictor of CR drop-out, the within-day
fluctuation and trajectory of state-anxiety as it relates to physical activity (a health behavior)
should be assessed.
A technique for assessing fluctuations in behavioral cognitions, affect, and feelings is
ecological momentary assessment (EMA). EMA is a method that uses repeated surveys to assess
feelings and experience in real time, in the participants natural environment (42). The benefits of
this method include reduced recall bias (due to momentary recall), measurements at multiple
time points to track temporal fluctuations, and improved ecological validity because the
participant completes the survey in their natural environment (42). Additionally, the repeated
sampling technique allows for within-person analysis. Whereas cross-sectional analyses only
describe relationships across the population, intensive longitudinal data can be analyzed to
describe variability within- and between-participants. A greater understanding of within-person
variability may help to develop novel interventions based on just-in-time adaptive interventions
or precision medicine (43, 44). To date, only one study has used EMA with CR patients. This
study investigated the temporal association of depression and physical activity in a small sample
(n=4) of men after myocardial infarction. The between-participant analysis upheld previous
findings of a negative relationship between depression and physical activity. However, the
within-participant analysis revealed that the longevity of depression effect on physical activity
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differed among participants, fluctuations in depression accounted for different variability in
physical activity among participants, and one participant exhibited a reverse effect where
physical activity preceded depression (45). Because anxiety is a predictor of CR drop-out (30),
physical activity can induce anxiety in the CR population (26), and regular physical activity is a
critical component of recovering from cardiovascular events (8), EMA should be used to
investigate time-varying fluctuations in anxiety in early phase II CR to investigate the
association between anxiety and physical activity.
Concurrent objective physical activity monitoring is suggested for use with EMA.
Physical activity monitors (PAMs) provide an objective measure of intensive longitudinal
physical activity data that is ecologically valid and, like EMA, can reduce the risk of recall bias
and provide a measure of subconscious physical activity (46). Several metrics representative of
physical activity are provided by PAMs but steps per day, specifically, is an intuitive metric (47)
that has been shown to motivate increased physical activity (48), steps have been associated with
health benefits (48-50), and they are a direct assessment of the most common form of physical
activity (51-53). In the CR setting, PAM-estimated step counts have been suggested to motivate
increased physical activity (54, 55), monitor exercise maintenance (56, 57), and measure postcardiac event rehabilitation (58). A current limitation to using PAM-estimated step counts is the
unknown step-counting error of research- and consumer-grade monitors for those in phase II CR.
Because steps are an intuitive and representative measure of most physical activity
completed throughout a typical day, they have the potential to provide an ecologically valid
measure of physical activity for those in CR they should be used along with in-the-moment
measurements of anxiety to map the trajectory and investigate within-person variability. These
assessments could provide in-depth information that better describes physical activity behavior.
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Investigating intra-individual trajectories and differences of these measurements may highlight
the complexity of repeated health behaviors and reveal insight for areas of improvement in
existing cardiac rehabilitation programs. Given the low participation and adherence rates of
phase II cardiac rehabilitation, understanding the complexity of physical activity and cognitive
and affective factors may aid in developing more efficacious and evidence-based cardiac
rehabilitation programs which yield better compliance and adherence.
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Cardiac Rehabilitation
Cardiac rehabilitation (CR) is a three-phased program, including educational, exercise,
and psychological counseling, aimed to help cardiac patients recover from a cardiac event,
reduce the risk of a secondary cardiac event, stop or slow the worsening of their current cardiac
condition, and help them return to their job and social life (1, 2). CR is often ordered for patients
who have experienced a myocardial infarction, coronary artery bypass graft surgery,
percutaneous coronary intervention, angina, heart transplant, valvular surgery, heart failure, or
peripheral artery disease, and may can include some pulmonary patients (3) and is delivered
beginning with the patients hospital stay and should be continued throughout the patient’s life
through a maintenance program (3).
Three main components of CR include exercise training, education, and risk factor and
behavioral modification (3, 4). Exercise training offers many benefits for individuals with
cardiovascular disease, including improved peak oxygen consumption 15-20% (5), completing
activities of daily living with more ease (self-reported) (6), the angina threshold is delayed or
completely ameliorated (7, 8), oxygen delivery to skeletal muscle is increased by greater
extraction at muscle (9, 10), greater capillary density within the skeletal muscle (11), and heart
size, stroke volume, cardiac output, and afterload are increased (10, 12). Education, risk factor
and behavioral modification are components of psychosocial management. Educational
opportunities offered in CR programs mainly focus on lifestyle modification, how to live with
cardiovascular disease, stress management, nutritional counseling, smoking cessation, and
exercise education programming. Nutritional counseling aims to reduce improve the lipid profile,
reduce weight, and improve blood glucose levels of participants while the exercise classes aim to
build maintenance after the patient completes the CR program (4). Risk factor assessments and
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behavioral modification plans are implemented on a more individualized level. The American
Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), the predominant
organization which outlines and certifies CR programs in the United States, suggests using an
individualized approach to assess the risk factors and behavior change that would most benefit
the patient while recognizing which behaviors they are willing and ready to alter. Additionally,
AACVPR suggests supplying patient’s education along with actionable plans and building selfreliance and self-monitoring skills to promote success and independence (3).
To be considered a CR program, the intervention must include those components outlined
by the AACVPR (exercise, education, and risk factor/behavioral modification) (4).
Comprehensive CR programs have shown many benefits including reduced all-cause and cardiac
mortality (2, 13), improved smoking cessation outcome (14), lowered blood pressure and total
cholesterol (14), improved health-related quality of life (15, 16), improved functional capacity
(16), and reduced the number of subsequent hospital visits and healthcare costs (13, 17, 18).
Some researchers have investigated exercise-only or psychosocial-only CR programs. Exerciseonly programs provided results similar to that of comprehensive programs with regard to allcause and cardiac mortality (19) but were not as effective in other areas such as smoking
cessation, blood pressure, and total cholesterol (14). Additionally, CR programs that do not
include exercise have reduced health-related quality of life outcomes (20). Long-term (12 month)
maintenance of reduced depression and improved health-related quality of life provided with a
comprehensive program (21).
Phases of cardiac rehabilitation. Phase I of CR is an inpatient program delivered
following a cardiovascular-related surgery or event and typically includes mobilization and early
education to prepare the patient for their return home from the hospital (3, 22). Mobility and
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readiness for education are first assessed on a case-by-case basis which directs the course of
phase I intervention. Mobilization in this phase typically includes a progression of movement
from the lying position, to sitting, standing, and ambulating, as well as simple movements of the
upper body and trunk (without resistance) (3). As progression continues, activities of daily living
(e.g., bathing, dressing, grooming) are included to aid in the safe transition from hospital stay
and independent living at home. The educational portion of phase I CR is also individualized for
the patient, with the main goal of educating them about safety and proper treatment for their
condition (e.g., proper medication use, contact information for physicians and other medical
assistance, lifestyle modification, follow-up outpatient programs) (3).
Phase II of CR is a medically supervised outpatient program that can begin within one
week of being discharged from the hospital (for uncomplicated percutaneous transluminal
coronary angioplasty with or without a stent (3)) or between 3 weeks to 6 months following more
complicated the surgical interventions (22). Phase II includes further assessment and
management of risk factors for CVD progression through exercise training (three times per
week) and educational sessions for lifestyle modification (3, 22). Exercise training is tailored to
the individual capabilities and needs of the patient. The primary type of exercise included in this
phase is aerobic, where the use of treadmills, stationary bikes, and other aerobic equipment is
common, however, resistance training can be included if tolerated (3, 13, 23). During the
exercise sessions, patients are continuously monitored (e.g., blood pressure, electrocardiogram,
heart rate) and are visually observed by nurses and exercise physiologists to foster a safe exercise
environment (3). Phase II programs require the presence of a supervising physician who
responds to any medical emergencies that arise during CR sessions and who also reviews the
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individualized treatment programs for those in the program. In total, this phase lasts 6 weeks or
36 sessions and the cost is typically covered by medical insurance and Medicare (3, 22).
Phase III is considered the maintenance phase of CR. Those who have successfully
completed phase II can enter a phase III program to continue their exercise and lifestyle
interventions. This, like phase II, is an outpatient program but monitoring of heart rate, blood
pressure, and ECG occur periodically, not continuously. Educational sessions are less common
during phase III and lifestyle coaching is also reduced; however, the level of these services can
vary amongst phase III programs. Individuals in the maintenance phase may have the
opportunity for more diverse exercise modalities like group fitness classes, resistance training,
water-based exercise, and restorative practices like yoga or tai-chi (3).
Cardiac rehabilitation attendance and adherence. Participation in CR is very low,
ranging from 20% to 35% (24-26). Initial referral, patient enrollment, and program adherence
each contain individual issues that contribute to the overall low participation rates. The issues
within each of these areas are not only related to participants, but also relate to the healthcare
system and overall hospital administration.
Two reasons for low initial participation rates, low referral (22) and enrollment rates (18),
stem from unclear communication among physicians and within the healthcare facilities. Referral
guidelines include that for cardiovascular disease management, CR is a Class I-Level
recommendation (the procedure/treatment should be performed/administered), based on clinical
practice guidelines established by the American College of Cardiology Foundation (ACCF) and
the American Heart Association (AHA) (27). Those that should be referred include patients with
recent myocardial infarction, acute coronary syndrome, chronic stable angina, heart failure, heart
or lung transplant, or who have undergone coronary artery bypass graft surgery, percutaneous
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coronary intervention, or valve surgery and referral can only be completed by a physician (1, 27,
28). Although the guidelines are seemingly straightforward, a gap in care exists when
determining the referring physician, which could be the patient’s cardiologist or the cardiologist
on call during hospital admission (3). Other reasons for reduced referral rates are lack of CR
locations nearby and lack of insurance (16). Characteristics of patients who experience reduced
referral rates are female gender, ethnic and racial minorities, older individuals (16, 28-30). A
simple intervention with the potential for a large impact for increasing referral rates is automatic
enrollment, based on cardiac diagnoses entered into electronic medical records. This method
detailed by Grace et al. (31) would automatically refer all patients with eligible diagnoses upon
their hospital discharge. Ades et al. (26) suggests this simple solution would triple referral rates.
Low enrollment rates are largely a consequence of gaps in care due to lack of follow up
with those who are referred, but do not enroll. Suggested methods of improving enrollment are
providing the patient with more individualized attention from a CR liaison to educate and assist
with referral and enrollment (e.g., referral and planned start date as a component of hospital
discharge), providing transportation or parking plan for CR attendance, and by providing choices
for type of CR program (e.g., home, community, or hospital-based program) (3, 28, 32).
Additionally, an important factor of enrollment is reducing the time delay between hospital
discharge and enrollment. Pack et al. (33) demonstrated that reducing the time between referral
and enrollment, from the average 35 days to 10 days, increased the percent of CR attendance
with no increased risk to patient safety. Interventions for the improvement of referral and
enrollment are largely suggested for the healthcare facilities. While other issues like attendance
and adherence should have interventions catered toward the participants.
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Attendance and adherence to CR programs is low with drop-out rates ranging from 40%
to 70% within the first 6 months (18, 26). Some common challenges to attendance and adherence
include the patients’ and physician’s perception of the efficacy of CR (34-36), female gender
(18, 24, 28, 37), older age (18, 35), low socioeconomic status (38), lower self-efficacy and
motivation (39, 40), and increased depression and anxiety (41-44). Of these challenges, higher
anxiety scores have been shown as an important and early predictor of adherence (42).
Anxiety. Anxiety is described as severe feelings of concern, worry, or anticipated threats
and tension along with physical characteristics including increased blood pressure, sweating, or
heart palpitations (45, 46). Two aspects of anxiety can be investigated: state and trait anxiety (47,
48). Trait anxiety has been described as a personality characteristic (or trait); stability in anxiety,
day to day, across all situations (47, 49). State anxiety, on the other hand, is the momentary or
temporary feeling (emotional state) of anxiousness one may experience in response to stimuli or
experiences (47).
Experiencing higher levels of anxiety has been associated with the development,
progression, and mortality related to cardiovascular disease (50-53). Hypertension, a common
physiological outcome of anxiety and major contributor to the development of cardiovascular
disease, predominates the theoretical association between anxiety and cardiovascular disease
development (50, 51). For those who have been hospitalized with a cardiac-related diagnosis, CR
has been shown to have an anxiety reducing effect (21, 54, 55), however, higher levels of anxiety
are also associated with CR drop out (42).
A critical review additionally noted anxiety as an under-researched yet contributing
factor to CR drop out (18). A study of 380 patients from a single CR program tracked patients
from their initial psychological assessments through the time they either dropped out or
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completed the program. Those who had the highest anxiety scores were individuals who dropped
out after completing the psychological assessments but before the initial walk test and exercise
session (early dropouts). The anxiety scores for the non-completers (those who left the program
early) had the second highest anxiety scores. Finally, the completers had the lowest baseline
anxiety scores. The scores between the completers and non-completers (both early and all
dropouts) were significantly different, thus revealing an early indicator of poor adherence and
potential opportunity for intervention (42). Similarly, Lavie and Milani (56) demonstrated that
baseline anxiety scores are significantly higher in non-completers of the CR program as
compared to completers. Interestingly, higher anxiety is also negatively associated with
adherence to physical activity following a CR program (57).
Further investigations surrounding anxiety, cardiac rehabilitation, and physical activity
are important as it is possible that decreasing anxiety levels of those in CR may improve
attendance and adherence. Bauer et al. (58) demonstrated that reducing depression and anxiety,
for those who were hospitalized for acute coronary syndrome, arrythmia, and heart failure,
improved several health behaviors, specifically adherence to CR through the first six weeks of
the program. This finding suggests that anxiety may be a point of intervention for improved
adherence to CR.
A current gap in the literature is understanding the role of anxiety in the decisional
process of deciding to engage in CR. Since CR is a repeated health promoting behavior, like
regular physical activity, the choice to engage in CR is likely dynamic, depending on the current
mood and emotional state of the participant. Currently, fluctuations in state-anxiety have been
demonstrated when sampled three times across an 11-day period (59) but to gain insight on the
impact of anxiety on the daily decision to engage in CR, one must first determine if this variable
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fluctuates across the day. The assumption of one singular, static measure of anxiety representing
the experience of an individual across an entire day is unlikely to represent their reality. To
understand the decisional process and the influence of anxiety, fluctuation must first be explored
across the day to map the trajectory of anxiety while also investigating within-person variability,
as this factor is likely to fluctuate differently among individuals. To accomplish this, repeatedmeasures sampling methods, like experience sampling or ecological momentary assessment,
should be implemented.
Ecological Momentary Assessment
Intensive longitudinal data. Traditional experimental research designs that employ
infrequent self-report assessments in laboratory settings can test theories of biological and
psychological processes and are necessary for experimental science (60). However, to
understand psychological and behavioral processes that lead to the outcome of interest as it
occurs in daily life, repeated assessments across the time period during which one exhibits said
behavior in the free-living environment are necessary (60, 61). Additionally, over the past three
decades, investigating individual-level or within-person responses in the natural, daily
environment have been highlighted with significance. Individually assessing outcomes can
elucidate how processes change per person and potentially direct key components of altering
behaviors, while capturing responses in the natural environment reveals responses as they occur
in reality, not controlled or influenced by a more clinical setting such as a doctor’s office or
laboratory (62-64).
Methods that include repeated samples in the free-living environment with analysis of
results on within-person basis, can be described as intensive longitudinal methods. Their aim is
to the improve ecological validity of measurements that provide descriptive statistics of

24

individual participants, allow for the investigation of within-person processes, and provide
temporal associations between behaviors and their concurrent psychological and physiological
states and environmental context (61). Additionally, this form of data collection reduces
reporting bias (e.g., recall and social desirability biases) and the summary of previous feelings or
moods, which is often a concern with self-reported information (60, 61).
There are several assessment techniques that fall under the umbrella of intensive
longitudinal design (e.g., ecological momentary assessment, experience sampling methods, and
ambulatory assessment). Within these techniques, diaries, surveys, event calendars, and objective
measures of variables can be utilized to capture intensive longitudinal data (ILD) (61). In the
health sciences, the primary technique used for collecting ILD is ecological momentary
assessment (EMA) (61).
Ecological momentary assessment. EMA is a technique used to collect self-reported
feelings, moods, behavioral cognitions, and contextual information in the moment, repeatedly
across time. It allows for the study of unstable variables (e.g., moods, feeling states) and episodic
behaviors as they change and are experienced across time or in response to events (65).
Additionally, with this form of ILD, within-subject analyses can be completed thereby providing
important information pertaining to how individual subjects react and respond to certain
situations and how their cognitive and behavioral factors fluctuation across time (65). Three
main tenants of EMA are (1) assessments must be momentary (i.e., responses are based on how
the participant feels “right this moment”), (2) measurements are repeated several times
throughout the period of inquiry, and (3) responses are captured in the natural, real-world
environment (65).
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Momentary assessments are necessary for capturing behaviors and feelings as they occur.
Momentary assessments reduce recall bias and error in reporting related to summarizing previous
feelings or experiences (65, 66). In non-momentary self-report survey questions, participants
may be asked to quantify an average amount of an autobiographical event over a specific period
of time (e.g., how many alcoholic drinks they have had over the past week). Bradburn et al. (67)
found that these responses tend to be unreliable, more so when occurrences of the event are
habitual throughout the timeframe under question. Additionally, retrospective autobiographical
questions have been found to be influenced by the respondent’s current state (e.g., retrospective
questions surrounding average pain are shown to be influenced by level of pain while completing
the survey or questions surrounding affect have been demonstrated to be biased by the current
affective state) (66, 68, 69) and self-reported mood also has been shown to be biased by the most
recent or a strongly emotion-changing event the participant experienced that day (70, 71). To
avoid the bias and reporting error associated with retrospective survey questions, momentary
assessments of the current state of the participant are suggested (72).
Repeated assessments improve the resolution of assessments by establishing withinperson dynamics of the factors of interest. Not only does increasing the number of assessments
reduce recall bias, but it also allows for the capture of changes in mood or affect that change
quickly or in response to a certain event (73). As stated earlier, when non-momentary
assessments are used, an effect of summarizing moods and behaviors distorts the overall
measurement as well as the strong influence of the participants current state (66, 69). Improving
the resolution of behaviors, experiences, and their outcomes is hypothesized to predict lapses in
negative health behaviors. For example, several studies have noted weak correlations between
average mood and lapses in smoking behavior, however, Shiffman et al. (74) found that
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regardless of the average level of negative affect, some smokers are more prone to lapse in
cessation during momentary instances of negative affect, therefore require a more tailored and
real-time intervention than others who are not affected by momentary negative affect. In this
study it was important to tease out average negative affect from momentary negative affect to
tease out those who are affected by momentary negative affect and those who are not. Dunton et
al. (75) suggests that repeated assessments are also necessary to better understand factors related
to engagement in health promoting behaviors, such as physical activity.
Capturing moods and behaviors in the real-world environment is necessary for
understanding the contextual factors of these outcomes. In order for data to be ecologically valid,
it must be collected in the natural environment (including physical location and social cues) of
the subject to reveal applicable information for intervention development (76, 77). Several
studies have noted that the context of physical environment (outdoors vs indoors) and being
alone versus with other individuals influences engagement in physical activity (78-80). Children
and adolescents both engage in more physical activity outside of the home and with other
individuals (not alone). Children, specifically, engaged in most physical activity in parks while
adolescents engaged in most walking at school and outdoors. The ability to identify the places
and situations where activities occur can be employed in interventions by suggesting physical
activity when individuals are near locations or in situations where activity regularly occurs (81).
Intensive longitudinal data, along with reducing recall bias, allowing for within-person
analyses, and providing contextual information to measurements, also allows for investigation of
behaviors and feelings as they change across time. Studying temporal associations describe
behavior change (the behavior and covariates) as it occurs within an individual. Accurately
describing behavior change is critical and necessary because this information can then be used to
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predict behavior by identifying causes and outcomes of behaviors. This study is not limited to
typical development as one ages, but also is used to describe other behaviors within individuals
like engagement in addictions, precursors to lapses when attempting behavior change, and
engagement in health-related, repeated behaviors (82).
The time-varying effect model is an approach for mapping behavior and other variables
over time, in order to describe the shape of behaviors change. This model is novel in that it does
not require the data to take a certain shape (e.g., linear, quadratic, exponential) and it allows for
fluctuations in factors of interest. Along with describing the shape of measurements, this model
also offers statistical methods to describe the relationship of behavior and covariates over time.
Briefly, the statistical model is similar to multilevel modeling, where relationships can be
described among several variables, with those variables being organized into several groupings
(82). To obtain data that support this type of analysis, EMA is an extraordinary strong method
due to the repeated, time stamped assessments (81). Describing data, such as fluctuations across
time, is a necessary method to ensure that relationships occur within-individuals, as has been
reported between-individuals (75).
Ecological momentary assessment in physical activity. Physical activity is a repeated
health promoting behavior that regular engagement at the suggested levels has been shown to
reduce the risk of cardiovascular disease, metabolic disorders, and breast and colon cancers, help
to maintain a healthy body weight, and promote bone health (83, 84). The current physical
activity guidelines for Americans suggest that adults engage in 150 to 300 minutes of aerobic
activity at a moderate intensity, 75 to 150 minutes of aerobic activity at a vigorous intensity, or a
combination that results in equivalent activity. Additionally, two days of week, or more, of
muscle strengthening activity per week is also suggested (84). To date, compliance rates of
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American adults meeting this guideline are unavailable, however, compliance with the previous
guidelines, which were identical recommendations for time and intensity but required aerobic
bouts to last a minimum of 10 minutes, were low. Compliance ranged from 10% to 62% based
on assessments via accelerometer or self-report, respectively, despite the health benefits (85).
Given the beneficial outcomes of regular participation in physical activity, improvements
to physical activity interventions are needed to improve compliance and extend activity
opportunities to the larger population. Some physical activity interventions are based on health
behavior theories. It has been suggested that current health behavior theories (e.g., Social
Cognitive Theory, Health Belief Model, and Theory of Planned Behavior) are largely based on
“limited occurrence” health behaviors (e.g., decisions made once per year like a yearly physical
or once every few years like maintaining vaccinations), which do not translate well to repeated
health behaviors (81, 86). In fact, meta-analyses comparing the effectiveness of theory-based and
non-theory based physical activity interventions demonstrated that theory-based interventions are
not more effective than those that are non-theory based (87-89). It is suggested that a limitation
to these theories is that they do not account for intra-individual and within-day fluctuating mood
states, feelings of affect, and other psychosocial variables or the influence of contextual factors
or temporal association (81, 82, 86, 90).
In addition to the high resolution of within-person and within-day psychosocial variables
and ecological validity, capturing physiological variables (91) as well as concurrent objective
measurement of physical activity (92) is unique to and suggested for use along with EMA of
physical activity. Several studies have investigated the feasibility of physical activity EMA while
others aimed to determine antecedents, correlates, and outcomes leading to and resulting from
physical activity.
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Some studies have used EMA to investigate associations between physical activity and
other factors in effort to describe ways in which variables are related to the decisional processes
that lead to engagement in physical activity and could provide the basis of EMI to promote and
increase physical activity. The following section will outline associations found with physical
activity that may shape future EMI.
Engagement in physical activity, especially intentional physical activity such as exercise,
requires forethought and planning. Fanning et al. (101) notes that time spent mind wandering is a
significant percent of our total daily thoughts and that this mind wandering is, in fact, useful for
planning and problem solving. In this study, participants were asked to respond to an hourly
EMA of mind wandering and affect across one week, while wearing an ActiGraph GT3X+
during all waking hours of each day. The main findings of this study were that episodes of mind
wandering, and positive affect were positively associated with higher levels of moderate to
vigorous physical activity (101).
A study by Dunton et al. (80) investigated the association between physical activity and
affect in adults. In this study, eight mobile surveys were delivered per day (across four days)
which assessed physical and social context, affect, and current level of physical activity. The
data were analyzed with multilevel modeling in order to determine if current physical activity
moderated affect across contexts. The results of this study showed that positive affect was
increased when being active with other people and being outdoors reduced negative affect. These
findings could be used to modulate affect in physical activity interventions.
Similar studies have been completed looking distinctly at physical location of physical
activity and at the predictive capacity of behavioral cognitions. In the study of physical location,
Liao et al. (102) found that physical activity and sedentary behavior typically occurred at home
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and most of these occurrences were while the participants were alone. Men completed more
moderate to vigorous physical activity outside, in public green spaces while women completed
more in their yard and driveway. Maher (103) found that of adults’ behavioral cognitions (e.g.,
intention, self-efficacy, outcome expectations) intention to be physically active positively
predicted physical activity in the morning and evening while self-efficacy positively predicted
physical activity on weekday evenings. This line of research, investigating cognitions, behaviors,
and temporal trends surrounding physical activity can identify time or situations of vulnerability
that could be intervened upon as to promote physical activity. In the same vein, using other
momentary factors, such as physical location along, could help to identify windows of
opportunity for physical activity, where a flexible intervention could be implemented (75, 81).
Ecological momentary assessment in cardiac rehabilitation. Only one study using EMA
as an assessment method has been conducted in a cardiac rehabilitation setting. This study
investigated the direction and temporal association between depression and physical activity in
five men who had previous myocardial infarction (104). This study revealed an overall negative
relationship between physical activity and depression levels, however, the authors noted
important intra-individual differences between the direction of the effect between depression and
physical activity. In some participants, physical activity was preceded by depression, and in
others, the reverse was true. Fluctuations in depression was shown to be explain more of the
variance in physical activity for one participant, but much less for others. Additionally, the
duration of the effect of depression on physical activity levels differed between participants. The
application of these findings are limited due to the all-male, small sample and the depressiononly focus, however, the results of this study represent the importance in accounting for intraindividual differences when exploring correlates and antecedents to physical activity behavior.
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Feasibility. Mobile EMA has been found to be feasible for children, college-aged and
vocational students, adults, and in some clinical populations (93-99).
Dunton et al. (93) completed a study assessing the feasibility of mobile EMA to assess
children’s physical activity and sedentary behavior. A small sample of children (N = 8, age range
= 9 to 13 yrs) were provided with a smartphone (HTC Shadow) with software for collection of
EMA data (MyExperience software) and all other features disabled. Children were prompted to
answer 20 mobile surveys (2-3 min in duration), sent at random times across a four-day period
(surveys were distributed outside of school hours). The surveys included questions of what they
were doing at that moment (e.g., sports, exercise, reading, watching TV), location, if they were
with other individuals, mood, and if they were enjoying the activity. Each child also wore an
ActiGraph GT2M accelerometer during their four days of participation so reports of physical
activity could be validated. In this study, the children answered 80% of surveys distributed and
reports of exercise and physical activity were validated with higher objectively measured
physical activity, indicating that self-reported activities were accurate.
An EMA was administered to a large sample (n=526) of adolescents, over the course of
four days, every six months. Participants were provided with a Palm III handheld computer,
heart rate monitor, and ActiGraph Mini-Motionlogger during the four days of monitoring. In this
study, surveys were delivered via a custom program on the Palm III. This program emitted an
audible beep every 30 minutes during waking hours which stimulated the participant to report the
activity they were currently engaging in. Participants resulted in a 75% compliance rate with
surveys. Activity and heart rate monitor compliance were not reported but the conclusion of this
study suggests that these all are feasible means to collect momentary activity data on adolescents
(94).
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In a large sample of adults (114), EMA of physical activity was also found to be a
feasible technique for assessing momentary activity. As outlined in the two previous studies, a
four-day EMA of current physical activity was administered using HTC Shadow smartphones
with MyExperience software. In this study, participants received eight surveys per day, assessing
the current activity they were engaged in. During this study participants also wore an ActiGraph
GT2M accelerometer for the objective measurement of activity and sedentary behavior. Overall
survey compliance was 82% but, importantly, survey compliance when wearing the
accelerometer was 85%. This should be a consideration when using EMA to assess physical
activity especially when the validity of activity reports are being assessed as the accelerometer
serves as the criterion measure (95).
Dunton and colleagues (94, 95, 100) demonstrated that from childhood to adulthood,
EMA of physical activity is feasible. High compliance rates (75% to 85% compliance) was
found for these groups. These studies also investigated the reliability of self-reported activity
when compared back to accelerometer output. Overall, when physical activity was reported, it
was supported by either higher step or activity counts, which indicated activity. This mapping is
important to understand the reliability of self-reported activity. However, the current
recommendation of objective monitoring along with EMA surveys remains as to capture the
more commonly forgotten activity such as light activities of daily living and active transport
(92).
The feasibility of EMA to assess physical activity has also been assessed in clinical and
middle-aged and clinical populations. Ehlers, Huberty (97) completed a mobile EMA aimed to
gather data about current physical activity, self-efficacy, and self-worth in middle-aged women.
Surveys were delivered to the participants own mobile phones via short message (which included
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a line to a Qualtrics survey) service two to three times throughout the day and during the survey
period, participants were asked to wear a GENEActiv activity monitor. Survey compliance in
this group was very high, with 91.1% of surveys being completed within the timeframe
requested. In this study the survey completion rate while wearing the activity monitor was
80.0%, slightly lower than that reported in younger adults. The results of a usability survey
administered at the conclusion of the study showed that 100% of the women agreed that the
mobile surveys were easy to complete, they did not take too long to complete, and it was easy to
read on the screen of the smartphone. The most common negative thought associated with this
study was that the activity monitor was challenging to wear, uncomfortable, or became
uncomfortable. Even with the negative feelings toward the accelerometer, the participants had
excellent accelerometer wear compliance with 99% during waking hours.
It is necessary to also consider the feasibility of mobile EMA in clinical populations,
especially due to the interest in this as a tool for behavior change. The feasibility of EMA
surveys and ecological momentary intervention (EMI) responses delivered via a mobile
application that participants downloaded to their smartphone. In this study, participants were
encouraged to complete nine educational modules and five surveys per day pertaining to weight
loss, in preparation for bariatric surgery. Each completed EMA survey triggered an EMI
response either praising the participant for engaging in healthy, weight loss behaviors, or
suggested exercise or engagement in a healthy behavior. The EMA responses were quite low
(only 30% completion rate) but an average of seven out of the nine education modules were
completed. Of benefit, those who participated in the study lost 7.3±4.4 kg of body weight as
compared to 4.2±7.8 kg of body weight for those who were eligible for the study but did not
participate (98). The findings of this study suggest that EMA/EMI is a feasible option for
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intervention delivery. The low response rate for the EMA was concerning in this study but
authors suggested that this could be the result of only allowing 60 minutes for a response to be
valid. They also included that extending beyond that time frame could detract from the
momentary analysis and therefore would not capture the variables properly (98).
Anxiety assessment. State-anxiety will be assessed using the six-item short-form of the
state scale of the Spielberger State-Trait Anxiety Inventory (STAI short form). State-anxiety is
related to temporary condition, emotion, or reaction to a situation and is largely momentary,
fluctuating throughout one day and varies from day to day (48). In general, anxiety has been
reported to negatively influences participation in cardiac rehabilitation (44, 105), associated with
early drop out from cardiac rehabilitation (44, 106), and for those who have suffered myocardial
infarction, anxiety is a predictor of impaired quality of life, as reported from 12-month follow-up
(44). Specifically, state-anxiety has been found to be higher for individuals who do not complete
cardiac rehabilitation (44) and for those who do not engage in cardiac rehabilitation at all (107).
The STAI short form will be used to assess this factor because it is highly correlated with
the original long form (r = .95) (108) and its brevity suits the requirements of repeated
measurements (four measurements per day) as this reduces participant burden (the original form
includes 20 items while the short form includes 6 items). The STAI short form was developed
and validated with pregnant women (108) and since has been used to assess state-anxiety with
several other populations, (e.g., those with gestational diabetes (109), older individuals (110),
those at risk for exposure to an outbreak of swine flu (111), management of hypertension (112),
and those undergoing computed tomography angiography (113).
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Physical Activity Monitors
Physical activity monitors (PAMs) are small, wearable devices that are used to
objectively assess physical activity. Physical activity metrics provided these monitors typically
includes step count per day, caloric expenditure, physical activity intensity or active minutes, and
distance ambulated. Of these metrics, the most intuitive and commonly used is steps per day,
therefore this review will focus on step count accuracy of the PAMs used in the current study.
Commonly, PAMs are small, wearable devices that contain at least contain an
accelerometer, battery, processing chip, and internal memory in a plastic housing, however, other
sensors may also measure heart rate, blood oxygen saturation, electrocardiogram waveforms,
altitude, and body temperature (114-116). To assess physical activity, PAMs measure the
changes in bodily accelerations and then process the raw acceleration data in ways that vary per
manufacturer. Thresholds that have been calibrated to criterion measurements representing
activity intensity or algorithms that are designed to count steps are then applied in order to
translate the acceleration data into metrics representative of physical activity (e.g., activity
counts, step counts) (116, 117).
Monitors are typically considered to fall within one of two categories: research-or
consumer-grade (114). Research-grade activity monitors are typified by physically storing all
raw data on the monitors physical memory, including a real-time clock within the device, and
requiring monitor-specific software for data processing, while consumer-grade monitors
typically transfer data at regular intervals to a separate computer or smartphone, are available for
retail purchase, and are considerably less expensive(114, 118). Where research-grade activity
monitors were once very commonly used, consumer-grade monitors are now considered an
option for clinical and population-level research. For example, two Fitbit monitors, Fitbit Charge
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2 and Alta, are used to track physical activity in the All of Us Study, a large cohort study
initiated by the National Institutes of Health. Additionally, according to a recent search of
clinicaltrials.gov, there are over 300 reported trials utilizing Fitbits in a variety of patient
populations including cancer, gastric bypass, spinal stenosis, joint replacement, cardiovascular
disease, and renal disease. Although there is a surge of consumer-grade monitor use, a similar
search of the most commonly used research-grade monitor, ActiGraph, on clinicaltrials.gov
returned over 600 studies utilizing this brand of monitor. Due to the wide use of both consumerand research-grade monitors, the accuracy of their measurements must be assessed.
Step count. Daily step counts are one of the most common and easily understood metrics
provided by activity monitors. Along with their intuitive nature, benefits of using daily step
counts as a metric include associations with positive health outcomes (e.g., accruing higher steps
per day has been associated with reduced risk of metabolic syndrome (119), reduced body mass
(120, 121), lowered systolic blood pressure (121)), they are a direct measure of walking and
jogging, two of the most common physical activities in the US (122-124), and they are a
motivator for increasing daily physical activity when a daily step count goal, along with
concurrent monitoring is used (121). As researchers increase their use of consumer-grade activity
monitors (114) and maintain use of research-grade monitors, it is necessary to investigate their
accuracy across a variety of populations (e.g., varied health status, ages, and body sizes) (125,
126).
Many studies have assessed step count accuracy across many devices during treadmill
ambulation, activities of daily living, and across all walking hours of a day. In general, findings
suggest that many devices under-count steps when walking speed falls below <80 m/min (127130), stepping is not continuous (e.g., bouts of stepping < 4 seconds in duration) or steps occur in
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an irregular pattern (e.g., stepping during vacuuming) (131-133). When monitors are worn on the
wrist, steps are over-estimated during non-ambulatory activities such as folding laundry (134)
and under-estimated when patients use assistive walking devices like canes and walkers (135137) or when healthy adults push strollers (131). Some other limitations of activity monitors
include the inability to capture non-ambulatory activity (e.g., swimming, cycling, rowing) (138),
data collection is dependent upon participants wearing the monitor, and monitors do not provide
the mode of activity or contextual information (e.g., geographical location, indoor or outdoor
setting, exercise versus physical activity) (81, 92).
StepWatch. The StepWatch activity monitor is a small and lightweight research grade,
step counting device (70 X 50 X 20 mm; 38g), that is worn on the side of the ankle, directly
above the lateral malleoli, affixed by a Velcro strap. This device is initialized using a docking
station attached to a computer with the Modus software installed. When initializing the
StepWatch, the participants height must be entered, age and weight are optional. Height impacts
the cadence and sensitivity step count settings for this monitor. The cadence setting determines
the duration of time that must be waited following one step, before another step can be counted.
To solve for the applied delay time, the cadence setting (reported by the Modus software
following initialization) can be multiplied by 0.01-sec. The sensitivity setting describes the
acceleration threshold that a participant must surpass to count a step (139).
There are several preprogrammed StepWatch settings that can help to tailor the cadence
and sensitivity settings for individuals with different gait patterns. The cadence and sensitivity
settings are based on four main criteria: 1.) if the participant engages in quick stepping, 2.)
walking speed, 3.) range of walking speeds, 4.) and leg motions. Based on the participants
typical gait pattern and walking speed, the researcher can select the appropriate options per
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participant and thus their cadence and sensitivity will be adjusted (140). To complete
initialization, an epoch for step reporting is selected (3-sec to 120-sec). The StepWatch has
limited memory so the selected epoch will determine the total number of days data can be
collected. At the shorted epoch selected, the StepWatch will be limited to 48 hours of data
collection, meanwhile when 120-sec is selected, 15 days of continuous data can be collected
(141).
At the end of the data collection period, data are downloaded by connecting to a docking
station attached to a computer with the Modus software. The Modus software provides total
stride count for the selected epoch (139, 142). To obtain total step count, researchers are required
to multiply the stride count by two in order to obtain total step count.
The step counting accuracy of the StepWatch has been assessed during treadmill walking
in several studies with healthy adults (132, 140, 143, 144). For speeds of 1.5 to 4.5 mph, Hickey
et al. (132) found the StepWatch to capture 99% of hand counted steps. Feito et al. (143) found
similar results for 1.5 to 3 mph and Toth et al. (140) additionally found that the StepWatch
captured 99% of hand counted steps between 2 and 4 mph while walking on a treadmill. At
speeds of 5 mph and greater, the step count error increases, however, Toth et al. (140)
determined that by adjusting the cadence setting to 70% of the default and by increasing the
sensitivity setting to 16, the range of treadmill walking and running speeds where the StepWatch
can capture within 5% of all hand counted steps is expanded from 2 to 10 mph. The StepWatch
step count accuracy has also been assessed and the monitor has been validated for several
clinical populations (e.g., Parkinson’s disease, post-stroke, multiple sclerosis) (145-148) and
those who walk slowly (e.g., elderly, COPD) (136, 149, 150).
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Bergman et al. (149) examined the step count validity of the StepWatch over a one-tenth
mile walk with older adults (N=21, mean age 78.6 yr) where average walking speed was 1.5
mph. Participants were asked to walk at a self-selected pace, continuously, for one-tenth mile
while wearing the StepWatch. All steps were hand counted during the trial which served as the
step count criterion for comparison. Overall, the StepWatch overestimated total steps by 2.5% (a
difference of 11 steps for an average trial of 433 hand counted steps). The DigiWalker SW-200,
another pedometer was included in this study and worn during the same trial. The DigiWalker
had greater step counting error, on average underestimating steps by 52%.
Similar to that of Bergman, Treacy et al. (150) investigated the validity of 8 step counting
monitors in a slow-walking population. In this study inpatient participants (N=166) ambulated at
speeds ranging from 0.9 to 2.7 mph and steps count accuracy was assessed during a 6 Minute
Walk Test. The StepWatch was the most accurate step counting monitor across all speeds,
maintaining a 98% agreement with GAITRite counted steps, the criterion step count used in this
study. Other monitors ranged from 84% agreement (Fitbit One) to 26% agreement (ActiGraph
GT3X+).
Laboratory based studies of activities of daily living have been completed to assess
PAMs during specific activities. Overall, the step count error is greater during activities of daily
living than during continuous walking. Hickey et al. (132) demonstrated that the percent error for
several multidirectional (13.5%) and side-to-side (10.6%) activities of daily living resulted in
increased error over that of forward-motion locomotor activities (6.2%). Similar results were
found by Toth et al. (140) where continuous treadmill ambulation ranged from 1 to 5% error but
expanded up to 12% error for vacuuming, tennis, cleaning counter tops, and dusting.
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In a study completed in the most ecologically valid setting, free-living across one day,
participants wore a chest mounted GoPro video camera and recorded all steps taken across one
day. At the same time, they wore several activity monitors, including four StepWatch activity
monitors, each initialized with a different quick start setting: (1) default, (2) quick stepping, (3)
both extremes (of walking speed), and (4) quick stepping with dynamic/fidgety leg motion. All
steps captured on the video were hand counted (criterion measure) and the total step counts from
each StepWatch were compared back to the criterion. The StepWatch results are as follows, each
percent representing the percent of hand counted steps: default setting captured 102%, both
extremes captured 97%, quick stepping captured 100%, and quick stepping with dynamic/fidgety
leg motion captured 94%. The StepWatch resulted in the least error of all monitors included in
this study, and due to the superior step counting accuracy of this device, it was concluded that it
could be confidently used as a criterion method for future studies investigating the error of step
counting monitors (118).
ActiGraph, LLC. ActiGraph, LLC (Pensacola, FL) is a research-grade activity monitor
manufacturer. Current ActiGraph activity monitors include ActiGraph GT3X+, ActiGraph
GT3X-BT, and ActiGraph GT9X. Only the GT9X will be detailed in the following section
because it was the only ActiGraph utilized in the current study.
ActiGraph GT9X Link. The ActiGraph GT9X Link (GT9X) is a small, lightweight (35 X
35 X 10mm, 14g) research-grade activity monitor that can be worn on the wrist, waist, ankle, or
thigh. This monitor includes a primary tri-axial accelerometer, an inertial measurement unit with
a secondary accelerometer, gyroscope, and magnetometer, and Bluetooth LE and USB
connectivity. This monitor is initialized by and data are downloaded with ActiLife software
(ActiGraph LLC, Pensacola, FL). Depending on initialization configuration, the battery life of
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GT9X monitors is up to 14 days (151). Three methods of processing GT9X step count data are
available. First, the ActiLife step counting algorithm is the basic algorithm included within the
ActiLife software. For slower walking or older individuals, the low-frequency extension can be
enabled, which broadens the bandpass filter, to allow more low end accelerations included for
step count analysis (152). Lastly, the Moving Average Vector Magnitude algorithm can be
applied to GT9X raw data (153).
Relatively few studies have investigated the step count accuracy of the GT9X worn on
the hip. The most comprehensive study is one described above, where total daily steps were
compared back to hand counted steps video recorded across one day. In this study, the GT9X
data were processed with the ActiLife algorithm, with the low-frequency extension, and with the
moving average vector magnitude algorithm. Across one day, the ActiLife algorithm was found
to undercount steps, capturing only 68% of hand counted steps. Enabling the low frequency
extension caused steps to be over-counted, capturing 126% of hand counted steps. Finally, the
moving average vector magnitude algorithm had similar outcomes as the ActiLife algorithm,
capturing 70% of hand counted steps (118).
Fitbit Charge 2. The Fitbit Charge 2 is a consumer-grade fitness tracker that is worn on
the wrist, placed one finger’s width away from the ulnar styloid process, toward the elbow(154).
It includes a tri-axial accelerometer, altimeter, and an optical heart rate tracker. Some of the
variables displayed are steps, sleep duration, heart rate, and gross caloric expenditure. Battery
life of this device is up to five days. Minute-by-minute physical activity data are saved for seven
days, and daily totals are saved for 30 days. This device includes an organic light-emitting diode
(OLED) display, allowing users to read data directly from the device, and can be synchronized
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with mobile devices (e.g., smartphones and tablets) and computers via Bluetooth LE wireless
connectivity (154, 155).
The majority of studies that have investigated the Fitbit Charge 2 focused on heart rate
accuracy. To date, no studies have assessed the step count error with this specific model. Many
studies, however, have investigated steps with the Fitbit Charge and Fitbit Charge HR (118, 133,
150, 156). In a laboratory based-study, participants were asked to wear a Charge and other
equipment while participating in 20 minutes of sedentary desk work, 25 minutes of aerobic
exercise, and 25 minutes of activities of daily living. Steps were collected before and after each
activity type and were compared to the criterion method for counting steps in this study, which
were step counts reported from a Yamax DigiWalker. The Charge captured 107.5% of
DigiWalker captured steps for all activities combined. Interestingly, the Charge captured an
average of 1002 steps during the activities of daily living, while the DigiWalker only captured an
average of 571 steps (156). This signifies a difference in sensitivity between these two monitors.
Because steps were not hand counted or a StepWatch was not included in this study, one cannot
determine if the Charge over or under-estimates true steps.
It was also noted that when systematically investigating intermittent walking, the step
counting algorithm includes a six second continuous step counting requirement. In this study,
participants were asked to walk a specific number of steps (4, 6, 8, 10, and 12), then pause for 10
seconds and repeat this for two minutes. The Charge did not begin to add steps to the overall
count until at least six seconds of stepping was completed. In the second part of the study,
participants were asked to take four steps and then rest for a certain length of time (1, 2, 4, 6, 8,
and 10 seconds) and repeat this for two minutes. This part of the study was completed in effort to
find the minimum rest time that would clear the step cache, thereby restarting the continuous
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stepping requirement. For the Charge, it was found that any rest longer than one second would
restart the stepping requirement. These findings of a six second stepping requirement and a pause
longer than one second would refresh this requirement are notable because these limitations
prevent short walking bouts (less than six seconds in duration) from being added to the aggregate
step count, thereby explaining some of the under-counted steps across one day (133).
When assessed with inpatient stroke rehabilitation patients where were older and slower
walking, it was noted that during a six-minute walk test, the percent agreement with directly
observed steps was poor, with only 52% agreement. Additionally, the intra-class correlation with
observed steps was low (ICC = 0.399). It was concluded that the poor agreement for the Charge
was largely driven by slow walking in this population. Upon grouping walking speeds, the
percentage accuracy of Charge monitors showed a steep decline at 0.59 m/s and slower speeds. It
was concluded that for very slow walking individuals, Charge monitors largely under-estimate
steps. Other monitors such as StepWatch and Fitbit One (worn on the ankle) would be more
appropriate for step count assessment for these individuals (150).
Fitbit Zip. The Fitbit Zip is a waist-worn consumer-grade wireless activity tracker. It is a
small and lightweight device (35.6 X 28.9 X 9.6mm, 8g) and can be worn in three locations
(waistband, pants pocket, or bra) attached via the silicone clip (157). This device includes a triaxial accelerometer and a replaceable watch battery that lasts up to 6 months. Step count, caloric
expenditure, distance ambulated, and active minutes are displayed on the LCD screen and the
device can sync with and display data on mobile devices (e.g., smartphones and tablets) and
computers via Bluetooth 4.0 wireless connectivity (158).
Several laboratory-based studies have investigated the step count accuracy of the Fitbit
Zip (159, 160). Huang et al. (159) investigated the Zip in three scenarios: flat, overground
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walking (400 m) at a self-selected speed, walking up and down 16 flights of stairs, and treadmill
walking at 2, 3, and 4 mph. The Zip results showed low error scores, missing 0.1 ± 0.6% (M ±
SD) of hand counted steps taken during the flat, overground walking, 1.1 ± 2.7% walking up
flights of stairs, and 5.3 ± 10.0% walking down flights of stairs. These results were not
significantly lower than any of the other devices assessed. No significant difference in error
scores between 2, 3, and 4 mph resulted from the treadmill walking conditions for the Zip. Each
speed resulted in slight step count underestimations (-2.7 ± 6.6, -5.8 ± 11.6 -3.4 ± 5.7,
respectively) (159).
Imboden et al. (160) specifically investigated the Zip in slow walking conditions (0.6
mph, 1.2 mph, and 1.9 mph). In this study, participants were asked to walk 100 steps while
wearing the monitor and error scores were calculated. Results showed the trend for step count
error to decrease as walking speed increased. In the 0.6 mph condition, percent error was quite
high at 96.0%, it decreased drastically to 17.3% in the 1.2 mph condition and was negligible at 0.7% for the 1.9 mph condition. For individuals who walk slower than 1.9 mph, the Zip should
be used with caution as this monitor will under-estimate steps (160).
Nelson et al. (134) investigated the step count error of the Zip during several activities
but added including household activities. Earlier studies showed low step count error for
continuous walking above 1.9 mph, however, the error associated with household activities was
much larger. The mean absolute percentage error for this activity was 70%. The mean absolute
error in terms of steps is challenging to interpret for this study, as the number of hand-counted
steps for the household activities are not published. In comparison to other monitors included in
this study, the Zip had showed a greater mean absolute percentage error than the Fitbit Flex
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(58%) and the Jawbone Up (54%), however, the Omron HJ-722 (79%) and Fitbit One (71%)
both had slightly greater error than the Zip (134).
Apple Watch Series 2. The Apple Watch Series 2 is a wrist-worn consumer-grade
smartwatch with fitness tracking capabilities. The Apple Watch Series 2 is sold in two sizes (38
and 42mm) and the unit chosen for this study is the smaller and lighter unit (38.6 X 33.3 X 11.4,
28.2g). Sensors included in this monitor are an optical heart rate sensor, tri-axial accelerometer,
gyroscope, and global positioning system (GPS) and data are displayed via an OLED display
(161). Physical activity estimates provided directly on the Apple Watch display include step
count, caloric expenditure, distance ambulated, and hourly stand count. A record of physical
activity and heart rate data is maintained by syncing the Apple Watch to an iPhone, via
Bluetooth 4.0 connectivity. The battery life of the Apple Watch Series 2 is approximately 18
hours (161, 162).
The Apple Watch is of particular interest to the medical community for its platform for
health-related research, integration of patient-driven health data with electronic medical records,
and opportunities for personalized health management for patients. The Apple ResearchKit
offers a platform, support, and framework for app development for health-related research. The
platform is designed for clinical trials, allowing for patient-driven, intensive longitudinal data to
be collected passively via the Apple Watch, supplementing the data collected from the app
created for the trial (163, 164). The Apple HealthKit allows for the collection and storage of
health-related data (both stable characteristics like allergies and chronic conditions and intensive
longitudinal data (i.e., step count per day and heart rate variability) all in one place. The
HealthKit is currently integrated with EPIC electronic health records (EMRs) and the Mayo
Clinic to supplement medical records with notes of symptoms, medication tracking,
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immunization records, and changes in health status (164, 165). Additionally, Apple CareKit is a
platform for creating apps that can help individuals track trends and changes in personal health,
symptoms, and medications and even communicate with health care teams to manage medical
conditions more effectively and on a more personalized basis (163).
Several studies have assessed the step count accuracy of the Apple Watch. The majority
of these studies assessed step count error with treadmill walking and running (166, 167). Wallen
et al. (167) examined the step count error of the Apple Watch during the first three stages of a
Bruce Treadmill test, with speeds ranging from 1.7 to 3.4 mph, beginning with a 10% grade in
the first stage and increasing to 14% grade in the third stage. The results of this study revealed
that steps were underestimated, when compared to hand counted steps, however Pearson’s
correlation coefficient between the Apple Watch and hand counted steps was strong (r = 0.70)
and the average step counting error of all devices included were low (4 to 6% error). Modave et
al. (166) completed a similar study of step count error and treadmill walking with the Apple
Watch Series 2, however this protocol included 1000 steps of treadmill walking at a self-selected
speed between 2 and 3 mph and stratified for three age groups (18-39, 40-64, 65-84 yrs). For the
18-39 and 40-64 yr age groups, the Apple Watch slightly undercounted steps, by 2 and 3%,
respectively, and slightly overestimated steps for the oldest group (2% overestimation). These
small errors were not significant for any of these age groups. One study by Veerabhadrappa et al.
(168) investigated step count error at three walking and one running speed (1.9, 3.0, 4.0, and 5.2
mph) on a treadmill. Compared to hand counted steps, the Apple Watch slightly overestimated
steps for all walking speeds (-2.6, -0.9, and -1.6%, at 1.9, 3.0, and 4.0 mph, respectively) and
slightly overestimated (3.4%) for jogging at 5.2 mph.
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To date, only one study has investigated the step count accuracy of an Apple Watch
during free living activities in a laboratory setting. Participants completed 25 minutes of freeliving activities (e.g., sweeping, stretching, and folding laundry), 20 minutes of sedentary
activities (e.g., using a laptop and reading a book), and 25 minutes of treadmill walking or
running at a self-selected speed. Step counts were assessed before and after each 20- or 25minute activity segment, thus activity specific error was not analyzed. During the free-living
activities, Apple Watch monitors overestimated steps resulting in a mean percent error of 148%,
steps taking during sedentary activities were underestimated by -272%, and treadmill walking or
running resulted in the least error, 0.7%. The authors suggested that the overestimation from the
free-living activities was due to the wrist-worn monitor capturing arm movements and misclassifying those movements as steps. It was noted that many of the activities included in this
protocol were non-ambulatory, but did require repetitive movements of the arms (156). An
overestimation of steps during non-ambulatory activities has been found with other wrist-worn
monitors like Fitbit Flex, Garmin Vivofit, and Jawbone Up (127) for folding laundry and the
Jawbone Up for outdoor cycling, washing and drying dishes, and rowing (169).
Steps per day and cardiac rehabilitation. Steps per day are an intuitive metric which are
scaled to the physical capabilities of participants (170). Specifically, in cardiac rehabilitation,
researchers have shown interest with using steps as a predictor of hospitalization (171) and as a
physical activity goal to meet in cardiac rehabilitation interventions or programs (172, 173) or a
more general goal for secondary prevention (174).
Takahashi et al. (171) gathered a sample steps per day, from inpatient cardiac surgery
patients, post-surgery. One year later, following the step collection, patients were asked to
complete a survey regarding their health condition. The purpose of this study was to determine if
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a certain inpatient step count value predicted cardiac re-hospitalization within one year of
discharge. From a sample of 133 patients, 16 were re-hospitalized within the year follow up.
These patients had significantly lower steps counts than those who were not re-hospitalized. The
cut point determined by the receiver operating curve was 1,308 steps per day. Out of several
other factors measured (e.g., anxiety and depression score, operation type, ejection fraction,
hospital stay length) the strongest predictor of cardiac re-hospitalization was a low step count
prior to discharge (Takahashi et al., 2015).
Steps goals have been integrated into cardiac rehabilitation interventions in order to
improve the participation in these programs. A study developed by Cupples et al. (173) invited
patients from a traditional cardiac rehabilitation program to join a community-based program
that aimed to promote continued physical activity following cardiac rehabilitation. The
intervention simply provided participants with an individualized step count goal per week, and
this was delivered by a clinical facilitator, who was a cardiac rehabilitation specialist. It was
found that this program, that was tailored for each participant was feasible for promotion of
continued physical activity. This simplistic intervention maintained and even was shown to
increase step count per week by about 2,000 steps (173).
Earlier work has determined a target step goal for the secondary prevention of CVD.
Researchers developed the goal by correlating step count with a range of caloric expenditure
above 1,000 kcal per week, which is a level that should be exceeded for secondary prevention.
The daily step count found to match this level of activity and provide adequate physical activity
as to protect against secondary cardiovascular events is an accumulation of 6,500 to 8,500 steps
per day (174).
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Determining cut points and interventions that aim to maintain physical activity and
protect against secondary events are necessary, but they also must be translatable, and the
monitors selected for measurement must be assessed. For example, in the study that determined a
target step goal for secondary prevention, the Kenz Lifecorder was used to assess step count
(174). It has been established that Lifecorder monitors undercount steps at walking speeds below
67 m/min (130), therefore it is likely that the goal recommended would be slightly higher if a
more sensitive monitor, like the StepWatch, was chosen for the original investigation. This and
the increasing popularity of reliance on wearable activity monitors and step count for tracking of
clinical populations (114) demonstrate the importance of investigating the error of these monitors
for various populations and to work towards harmonization among monitor manufacturers.
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Chapter III
Step Count Error of Activity Monitors for Patients in Phase II Cardiac Rehabilitation
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Abstract
Purpose: To investigate the step counting error of four wearable physical activity monitors
compared to StepWatch (SW) steps across the day for patients in Phase II cardiac rehabilitation
(CR) during free-living. Methods: Nineteen phase II CR patients (mean ± SD, 68 ± 7 yr, BMI
31.7 ± 14.7 kg/m2) wore a StepWatch (SW; criterion step method) on the ankle for five
consecutive days. For the first 2.5 days participants also wore one wrist and one waist worn
monitor, then replaced those with different wrist and waist worn monitors for the last 2.5 days.
Monitors included in this study were Fitbit Charge 2 (Charge) and Apple Watch Series 2 (Apple)
on the non-dominant wrist and Fitbit Zip and ActiGraph GT9X (GT9X) on the waist. GT9X
steps were processed with and without the low-frequency extension (LFE) and with the moving
average vector magnitude algorithm. Daily steps for each monitor were summed across selfreported wear time, converted to percent of SW steps, and compared across three conditions;
days attended CR (ACR), days attended CR with CR removed (AACR), and whole days without
CR (NCR). Results: Step counts from all monitors were significantly different from 100% of
SW steps, except for the Apple in ACR and Charge in ACR and AACR conditions. Steps were
underestimated when compared to SW steps for most monitors (range 5% to 55%) except for
overestimates in AGLFE (34% to 59%) and Charge in the AACR condition (2%). Conclusion:
For those in phase II CR, the Charge and Apple yielded the least stepping error when compared
to SW steps and time spent in CR did not greatly contribute to error for this population.
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Introduction
Worldwide, wearable physical activity monitors (PAMs) are a multibillion-dollar
industry (1). PAMs are popular among consumers for goal setting, personal tracking, and
motivation (2) and for researchers, these monitors allow for continuous and passive physical
activity surveillance (3). Use of PAMs in health care is growing as physicians and clinicians gain
interest in using them to track disease progression, recovery following surgery, and in homebased rehabilitation programs (4).
Several measures of physical activity are typically provided by PAMs (e.g., minutes of
aerobic exercise, caloric expenditure, daily steps), but an easily understood outcome available on
almost all monitors are steps. Steps are a direct assessment of walking, which is the most
commonly reported physical activity by American adults (5), and also is common to
occupational, transportation, and household activities (6, 7). Physical activity interventions
aimed at increasing daily steps have been shown to reduce waist girth (8), resting heart rate (8),
body mass (9), systolic blood pressure (2), high-sensitivity C reactive protein (10) and improve
blood lipid profiles (11). Stepping goals also provide motivation for increased total physical
activity (2).
For those diagnosed with cardiovascular disease or who have experienced a cardiac
event, cardiac rehabilitation (CR), an exercise and education program, is suggested to help
patients regain cardiac function to return to their careers and social life, reduce the risk of a
secondary cardiac event, and to delay or slow the progression of CVD (12-14). Although
improvements in cardiac function and overall health are well established results of CR
attendance (13, 14), adherence to classic CR programs is relatively poor, with a 40% to 70%
dropout rate within six months of beginning a CR program (15). To improve CR compliance and
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overall engagement in regular physical activity for those with CVD, the Million Hearts Initiative
of the U.S. Department of Health and Human Services established a need for innovative homebased or hybrid CR interventions that include mobile monitoring technologies such as PAMs
(16). Additionally, the use of pedometers to measure baseline physical activity for those in CR
have been suggested to guide physical activity counseling as a core component to align with the
American Heart Association/American College of Cardiology Secondary Prevention Guidelines
(17).
Due to the increasing interest of using PAMs and step counting in health care settings (4),
investigating the daily step counting error in various clinical populations is needed. In order to
provide a criterion measure of steps across the day, StepWatch 3 Activity Monitor (SW) was
selected because when compared to video-recorded, hand-counted steps across one single day,
the SW was shown to capture 102% of hand-counted steps (18). The purpose of this study was to
investigate the daily error in steps, as compared to SW steps, in Fitbit Charge 2, Fitbit Zip, Apple
Watch Series 2, and ActiGraph GT9X monitors for phase II CR patients.
Methods
Participants and Recruitment
Adult participants between 18 and 80 years of age were recruited from the phase II
cardiac rehabilitation program at the Heart Lung Vascular Institute of the University of
Tennessee Medical Center in Knoxville, TN. Individuals with < 35% ejection fraction, a
diagnosis of a disease with memory or cognitive decline, who could not engage in the exercise
portion of CR, who could not walk without an assistive device, or have had heart valve surgery
or valve replacement were excluded from participating in the study. The research protocol was
approved by the Institutional Review Boards of The University of Tennessee Health Sciences
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Center and The University of Tennessee, Knoxville campus. All participants provided written
informed consent before participating.
Eligibility was determined with a two-step screening process. First, CR nurses and
exercise physiologists reviewed the health-related exclusionary criteria (i.e., ejection fraction
<35%, diagnosed with conditions related to cognitive decline, memory impairment, or
pulmonary disease, and referred to CR following valvular surgery or heart transplant) for each
patient in the CR program and each new patient who entered during the four month data
collection period (February to June 2019) to determine eligibility. Those who were determined to
be eligible were referred to the researcher who met with each patient individually at a CR session
and confirmed eligibility based on the need of assistive walking device. The researcher then
explained the study requirements and written informed consent was collected from each patient
who agreed to participate.
Protocol
Participants were asked to wear an activity monitor on their non-dominant wrist, over the
right hip, and on their right ankle for five weekdays (Monday through Friday). The five days of
participation were divided into two periods (2.5 days each), with a different wrist (Fitbit Charge
2 and Apple Watch Series 2) and waist (ActiGraph GT9X and Fitbit Zip) monitor worn during
the first and second period. The ankle worn SW was worn for all five days and used as the
criterion estimate of steps. Wrist and waist worn monitors were randomized so each participant
would receive one of the two wrist and waist worn monitors for the first study period and the
other wrist and waist monitors for the second period.
On the first day, the researcher met each participant before their first CR session of the
week, showed them how to wear the SW and each monitor that was randomized to them for the
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first study period, and how to record monitor wear time on a paper log provided to them. The
participant then affixed the fully charged monitors, logged the time of day on the data sheet, and
went about their day. Participants were asked to wear the monitors throughout the entire day
except during times of bathing or swimming. At the end of the day, before participants went to
bed, they were asked to remove the monitors and record the time at which they were removed.
On the following day, day two, participants were asked to wear all three monitors from
the time they woke up in the morning until the time they went to bed in the evening and to record
these times on the wear time log. On day three, participants were asked to affix the monitors in
the morning upon waking and record the time of day. The researcher then met each participant
before their CR session, asked them to remove the wrist and waist worn monitors, recorded the
time of day they were removed, and provided each participant with the second pair of monitors.
Participants were instructed on how to wear the new monitors and were asked to wear them until
they went to bed. On day four the participants were asked to follow the same protocol as day
two. On the fifth day, participants affixed the monitors in the morning after waking up, recorded
the time of day, and wore them until they met the researcher before their CR session and were
asked to remove the monitors. All three monitors and data recording sheet were collected.
Physical Activity Monitors
Apple Watch Series 2. The Apple Watch Series 2 (software version 5.1.3, [Apple]) is a
wrist worn consumer-grade smartwatch with physical activity tracking capabilities. The Apple
Watch is available in two screen sizes (38 and 42 mm); the unit chosen for this study was the
smaller and lighter unit (38.6 × 33.3 × 11.4 mm, 28.2 g, 38 mm screen). Sensors included in this
unit are a tri-axial accelerometer, gyroscope, optical heart rate sensor, and global positioning
system (GPS). Physical activity data includes steps, active caloric expenditure, minutes of
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exercise, distance ambulated, and a count of hours where standing and moving for at least one
minute was detected at least once. It only synchronizes with iPhones which uses Bluetooth 4.0
connectivity. The battery life on this model is approximately 18 hours (19, 20).
Prior to each participant starting, the Apple was synchronized to an iPhone with the My
Watch mobile app using the participant’s height, weight, and birthdate, left or right wrist
placement and heart rate monitoring was disabled. Due to the short battery life, the Apple
required nightly charging, so each participant was provided with an Apple charger to charge the
monitor at night while sleeping. Minute-by-minute step count data from the Apple could not be
extracted, so participants were asked to record step counts in the morning and in the evening on
the wear time log.
Fitbit Charge 2. The Fitbit Charge 2 (firmware version 22.55.2, [Charge]) is a consumergrade, wrist worn fitness tracker (218.4 × 22.8 × 12.7 mm, 34.9 g). The manufacturer’s
suggested wear location is one finger’s width away from the ulnar styloid process, in the
direction of the elbow (21). The Charge includes a tri-axial accelerometer, altimeter, and optical
heart rate tracker and has a battery life of up to five days. Steps, heart rate, and gross caloric
expenditure for the current day are displayed on the screen of the monitor, but minute-by-minute
physical activity data are stored on the internal memory for seven days and daily totals are saved
for 30 days. Users can access hourly totals after synchronizing to the Fitbit mobile app (for
Android or iOS) via Bluetooth connectivity but minute-by-minute data are only available
through third party programs (21). Battery life on this device is estimated at 5 days, however,
disabling heart rate detection can improve battery life (22).
Fitbit Zip. The Fitbit Zip (firmware version 90, [Zip]) is a waist worn consumer-grade
activity tracker. It is a small (35.6 × 28.9 × 9.6 mm) and lightweight monitor (8 g) that can be
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worn on the waistband, bra, or in a pocket (23). The Zip includes a tri-axial accelerometer and a
replaceable watch battery (CR2025) that lasts up to 6 months. Total steps, caloric expenditure,
distance ambulated, and active minutes for the current day are displayed on the LCD screen of
the monitor but minute-by-minute physical activity data are stored on the internal memory for
seven days and can be retrieved with synchronization with a smartphone and the Fitbit mobile
app via Bluetooth 4.0 wireless connectivity. Hourly physical activity data are available on the
app, but minute-by-minute data are only available through third-party programs. Physical
activity data be displayed and stored on the Fitbit mobile app (for Android and iOS) (24).
Fitabase. Fitbit and Fitabase (Small Steps Labs, LLC, San Diego, CA) accounts were
created for each Fitbit monitor. Before participation, each participant’s height, weight, and
birthdate were entered into the Fitbit account through the Fitbit mobile app via iPhone and heart
rate detection was disabled. For the Charge, wrist preference (left or right) for wearing the
monitor was selected. The app and monitor were then synchronized. Following participation,
Fitbits were synchronized with the Fitbit mobile app which transferred minute-by-minute step
data to the Fitbit servers then were then extracted using Fitabase; a paid third-party program that
can access date and time-stamped, minute-by-minute Fitbit data.
ActiGraph GT9X. The ActiGraph GT9X (firmware version 1.7.2, [GT9X]) is a small (35
X 35 X 10 mm), lightweight (14 g) research-grade activity monitor that can be worn on the wrist,
waist, ankle, or thigh. This monitor includes a primary tri-axial accelerometer, an inertial
measurement unit with a secondary accelerometer, gyroscope, and magnetometer, Bluetooth LE,
and USB connectivity via a GT9X docking station. Depending on initialization configuration, the
battery life of GT9X monitors is up to 14 days (25).
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Before participation, AG monitors were initialized to be worn on the waist and to sample
data at 30 Hz using the ActiLife software (ActiGraph LLC, Pensacola, FL, version 6.13.3).
Following GT9X wear, data were downloaded using ActiLife software which was used to
generate steps per 60 seconds with the low-frequency extension enabled (AGLFE) and without it
(AG). Additionally, ActiGraph’s moving average vector magnitude (MAVM) algorithm was
applied to each raw acceleration file using specialized Scilab (Scilab Enterprises, Rungis,
France) and R (R core team) code in order to retrieve minute-by-minute MAVM steps. MAVM
steps can also be read from the screen of the GT9X.
StepWatch 3 Activity Monitor. The StepWatch 3 Activity Monitor (SW) is a small (70 ×
50 × 20 mm) and lightweight (38 g) research-grade, activity monitor that is worn on the lateral
aspect of the ankle, directly above the lateral malleoli, affixed by a Velcro strap. SW monitors
are initialized with the participants height and weight via a dock that connects to a computer with
Modus Health software. This monitor includes a non-rechargeable battery which lasts up to 7
years and an internal memory that can hold up to 50 days of stepping data (26).
SW activity monitors were initialized with the Modus Health software (Edmonds, WA,
software version 3.4) by entering the participant’s height and weight, selecting the default
cadence and sensitivity settings, and selecting the options for normal walking speed, uses a
moderate range of speeds, and normal leg motions. Steps were stored in 60-sec epochs because
this provided enough memory which allowed participants to wear the same SW for all five days
of the study. After participation, SW data were downloaded using the Modus software which
provided date and time-stamped steps in 60-sec epochs.
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Data Analysis
First, steps per minute were summed across the self-reported wear time for each day for
the SW, Charge, Zip, and AG monitors. Missing data were days when less than 500 steps were
counted and for those days only the monitor with missing data was excluded from analysis. This
produced two conditions, daily steps for days they attended CR (ACR) and for when they did not
attend CR (NCR). Next, steps during each CR session (60-min duration) were summed and
subtracted from the daily total for each monitor, including the criterion, on CR days. This
produced the third condition, adjusted ACR (AACR). Adjustments were made to determine if
CR impacted the magnitude of the error in steps. For Apple monitors, daily steps were found by
subtracting the morning steps from the evening steps. Because minute-by-minute data was not
available, the AACR condition could not be investigated for the Apple monitor.
The first, third, and fifth days of the study yielded steps across partial days. In the first
study period, during the first day, monitors were affixed before the CR session and were
removed at night before bed. On the morning of the third day, they were affixed in the morning
upon waking, but were removed before the CR session. Steps from these partial days, within the
same study period were added to create a single day for each monitor. In the second study
period, steps from the second half of the third day, which included the CR session through
removal before bed, were added to the step values on the fifth day (wake through the beginning
of the CR session). Concatenating these days within the same study period was performed in
order to report results in units of steps per day. The second and fourth days represented all
waking hours of one day, therefore no treatment was necessary.
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Statistical analysis
For each monitor and method, mean ± standard deviation, mean bias (criterion – step
estimate), and mean absolute percent error (MAPE) were calculated. Steps were converted to
percent of SW steps ((monitor estimate / SW steps) × 100) for statistical analysis to scale all data
points so days with higher steps did not weight the sample (18, 27). Repeated measures analysis
of variance (ANOVA) was used to compare the conditions (ACR, AACR, and NCR) separately
for each estimated step method. One sample t-tests were used to determine if the percent of SW
steps from each monitor, for each condition, was significantly different from 100% of SW steps.
Statistical analysis was completed with SPSS Version 25 for Windows, (SPSS Inc., Chicago, IL).
Results
Nineteen adult participants were recruited. A summary of participant characteristics is
presented in Table 1. The participants were predominately right-handed (89%) and male (84%).
Across the entire sample, a total of 9 days of missing data (days when no steps were counted by a
monitor) were found for SW steps, accounting for 8% of the entire sample. For the other
monitors, the percentage of missing days varied as follows: AG (14%), AGLFE (14%),
AGMAVM (28%), Charge (5%), Zip (2%), and Apple (9%).
Mean steps per day, mean bias, and MAPE are shown in Table 2 and percent of SW steps
are presented in Figure 1. The results of the repeated measures ANOVA showed that percent of
SW steps differed significantly among the ACR, AACR, and NCR conditions for AGMAVM
[F(1.9, 11.2)=4.5, p =0.04] but post hoc tests using Bonferroni correction showed no significant
differences among the conditions (p > 0.05). For the other monitors, no differences among the
three conditions were found (p > 0.05). Of note, the Apple was not included in this analysis since
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Table 1. Summary of participant characteristics.
All (N = 19)

Men (n = 16)

Women (n = 3)

Age (yr)

68 ± 7

67 ± 7.2

70 ± 5.1

Height (cm)

178.1 ± 8.6

180.3 ± 7.4

165.9 ± 6.4

Weight (kg)

100.4 ± 14.7

103.5 ± 12.7

84.1 ± 18.9

BMI (kg/m2)

31.7 ± 4.7

31.9 ± 4.0

31.0 ± 9.2

Reason for
CR

MI and Stent: 3
Stent: 9
CABG: 7

MI and Stent: 1
Stent: 8
CABG: 7

MI and Stent: 2
Stent: 1
CABG: 0
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Table 2. Summary of step data for each monitor and each condition.
95% CI
Mean ± SD
Monitor
Condition
N
Mean bias
MAPE (%)
steps per day
LL
UL
ACR
37
5204 ± 2496
SW
AACR
33
3375 ± 2242
NCR
35
8418 ± 4225
ACR*
17
3514 ± 1155
1690
38.2
-47.4
-27.5
AG
AACR*
13
2267 ± 1152
1108
40.1
-51.8
-0.6
NCR*
16
4348 ± 2658
4070
49.8
-56.8
-42.7
ACR*
17
7473 ± 2596
-2269
34.0
12.3
55.7
AGLFE
AACR*
13
5396 ± 2900
-2021
80.3
14.2
145.4
NCR*
16
10614 ± 4286
-2196
34.9
19.0
50.7
ACR*
16
2666 ± 1116
2538
55.2
-64.6
-45.8
AGMAVM
AACR*
9
1360 ± 664
2015
48.4
-70.7
-26.0
NCR*
15
3128 ± 2214
5290
63.4
-71.7
-55.5
ACR
18
4293 ± 1212
911
31.7
-27.5
0.9
Apple
AACR
NCR*
16
5594 ± 2602
2824
27.9
-37.8
-7.6
ACR*
18
4562 ± 2655
642
33.1
-31.6
-4.7
Charge
AACR
13
3276 ± 2212
99
47.1
-41.2
17.4
NCR*
17
6180 ± 3501
2238
27.7
-35.5
-11.6
ACR*
18
3202 ± 1955
2002
34.4
-38.3
-22.4
Zip
AACR*
17
2326 ± 1815
1049
33.9
-44.5
-17.0
NCR*
16
5329 ± 3387
3089
42.2
-50.0
-21.0
MAPE, Mean Absolute Percent Error; 95% CI, 95% Confidence Interval; LL, lower level; UL, upper level; SW, StepWatch3 Activity
Monitor; AG, ActiGraph without low frequency extension; AGLFE, ActiGraph with low frequency extension; AGMAVM, ActiGraph
with moving average vector magnitude algorithm; Apple, Apple Watch Series 2; Charge, Fitbit Charge 2; Zip, Fitbit Zip; ACR,
Attended cardiac rehabilitation; AACR, Adjusted attended cardiac rehabilitation; NCR, no cardiac rehabilitation.
*
Significantly different from StepWatch steps to 100% (p < 0.05).
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Figure 1. Percent of StepWatch Steps for each monitor (AG, ActiGraph without low frequency extension; AGLFE, ActiGraph with
low frequency extension; AGMAVM, ActiGraph with moving average vector magnitude algorithm; Apple, Apple Watch Series 2;
Charge, Fitbit Charge 2; Zip, Fitbit Zip) during each condition (ACR, Attended cardiac rehabilitation; AACR, Adjusted attended
cardiac rehabilitation; NCR, no cardiac rehabilitation). Horizontal bar represents 100% of StepWatch steps and error bars represent
standard deviation.
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the AACR condition could not be determined because this analysis required the removal of all
steps taken during CR and without minute-by-minute steps, this was not possible.
Compared to the SW, steps were significantly underestimated during each condition
(ACR, AACR, and NCR) for the AG (range: 34% to 50%, p < 0.05), AGMAVM (range: 55% to
64%, p < 0.01), and Zip (range: 27% to 35%, p < 0.001) monitors. The Charge significantly
underestimated SW steps for the NCR (24%, p = 0.001). Results showed the Charge slightly
underestimated for ACR (8%, p > 0.05) and slightly overestimated AACR conditions (102%, p >
0.05), both of which were not significantly different from 100% of SW steps. The Apple
significantly underestimated SW steps for the NCR condition (23%, p > 0.01) but not for the
ACR condition (5%, p > 0.05). The AGLFE overestimated steps per day (range: 34% to 59%, p
< 0.05) for all three conditions. During time spent in CR, steps were underestimated by each
monitor (range: 5% to 54% of SW steps) (Figure 2). The Charge and Apple had the lowest
MAPE values, both for the NCR condition, 27.7% and 27.9%, respectively. All other MAPE
values were above 30% with the highest value being 80.3% for the AACR condition of AGLFE.
Discussion
The Charge (ACR and AACR) and Apple (ACR) both captured within 10% of SW steps for
patients in phase II CR. The AG, AGMAVM, and Zip significantly underestimated SW steps per
day, on days when they attended a CR session (non-adjusted values) and days when they did not.
The MAVM method underestimated to the greatest extent (55% to 64%) and the AGLFE was the
only method to overestimate for the ACR and NCR conditions. For the adjusted steps, the AG,
Charge, and Zip monitors captured a slightly greater percentage of SW steps, and the Charge
slightly exceeded 100% of SW steps. This adjustment, however, removed 60 minutes of daily
activity from each monitor which renders these results less useful for practical application
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Figure 2. Percent of StepWatch steps for each monitor (AG, ActiGraph without low frequency
extension; AGLFE, ActiGraph with low frequency extension; AGMAVM, ActiGraph with
moving average vector magnitude algorithm; Apple, Apple Watch Series 2; Charge, Fitbit
Charge 2; Zip, Fitbit Zip) during cardiac rehabilitation sessions. Horizontal bar represents 100%
of StepWatch steps and error bars represent standard deviation.
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when considering that monitors are worn across an entire day. Steps were underestimated by 5%
to 54% during CR sessions.
Underestimated total daily steps for each of the monitors, except for AGLFE, were
similar to the results of an earlier study comparing multiple monitors to hand-counted, video
recorded steps across a single day, in young, healthy adults (18). Results showed the Fitbit
Charge, Fitbit Zip, and waist worn GT9X without LFE and with MAVM underestimated steps
when compared to hand-counted steps by 23%, 25%, 31%, and 30%, respectively while the
ActiGraph with LFE worn on the waist overestimated by 26% of hand counted steps. During
NCR days, days similar to healthy adults without a gym-based exercise session, current findings
show the Charge (24%), Zip (35%), and AGLFE (35%) similarly underestimate steps, with error
within 10% of the earlier study. The AG (50%) and AGMAVM (64%) showed greater
differences between populations. Of note, different criterion methods were used in these studies,
but the SW was shown to capture within 2% of hand-counted steps, thus the criterion steps are
comparable (18).
The commonality of underestimated steps may be related to consecutive stepping
requirements used in step counting algorithms. The step counting algorithms in several PAMs
include a consecutive stepping requirement that only adds steps to the aggregate count once a
stepping bout exceeds 4-6 steps (or 4-6 seconds) that occur in succession, without pause (27). If
a bout ends before 4-6 steps are accumulated or before the continuous movement requirement
has been met, those steps are discarded and are not included in the aggregate total. The purpose
of this is to prevent miscellaneous, non-ambulatory movements from being incorrectly counted
as steps (27). However, it is possible that many short bouts of steps are not added to the
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aggregate bout because bouts four steps or less are the most common stepping bout taken across
the day, accounting for 17% of total stepping bouts (28).
In a study of continuous stepping requirements, regardless of stepping bout duration and
varied pause lengths between bouts, the SW was shown to collect within 10% of hand-counted
steps. Not only is the SW sensitive to capturing slow, light steps, it does not require continuous
walking to accumulate steps, thereby it captures a greater percentage of hand counted steps than
the other monitors (27, 29). The Fitbit Charge and the Zip were found to require eight and six
continuous steps, respectively, before adding steps to the aggregate count and a pause of at least
one second would end a bout for these monitors. Waist worn ActiGraph GT3X monitors with
and without LFE captured steps consistently across all stepping conditions, suggesting a
continuous stepping requirement is not included in this algorithm. For the MAVM algorithm, a
greater percent of hand-counted steps were captured following a continuous bout of six steps.
Additionally, with the MAVM, a pause of at least two seconds reduced the number of steps
captured, suggesting that the MAVM algorithm requires at least two seconds of continuous
walking before accumulating steps when worn on the waist and a pause of two seconds will end
a bout (27).
Some activities of daily living and movement patterns have been demonstrated as sources
of step counting error. Walking slower than 2 mph and multidirectional movements have been
shown to cause undercounted steps. In slow walking the acceleration signal created during heel
strike is insufficient to trigger a step (30, 31) and in some cases, this could be true for
multidirectional movement. However, steps are also undercounted during tennis and ballroom
dancing, which create larger acceleration signals that should be captured (29, 32). Specific to
wrist worn monitors, activities where the hands are placed on a stable support while ambulating
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(e.g., pushing a stroller) will prevent steps from being counted as the acceleration required to
trigger a step is attenuated by the stable object (33). Conversely, activities like folding laundry
and washing dishes (33, 34) have been shown to overestimate steps, however, the extent to
which steps are undercounted masks this error across the day. For waist and ankle worn
monitors, cycling (35) causes steps to be overcounted. Cycling was a common activity for those
in CR, but the relatively short time participants cycled (<5 min/day) did not overcome the overall
trend in undercounting steps across the day.
The AGLFE was the only monitor to vastly overcount steps. The LFE reduces the
attenuation of the low frequency accelerations that occur at the lower end of the physical activity
intensity spectrum. This was done for the purpose of aligning the acceleration outputs for the
GT3X with the older ActiGraph 7164 (36); it was not done to improve step counting accuracy.
Nevertheless, enabling the LFE improves step estimates for older, slower moving individuals
(37) but greatly overestimates daily steps for healthy adults (18). Hickey et al. (38) found that
when the LFE is enabled, false-positive steps are captured during light, non-ambulatory activities
such as filing papers and they suggest that this could be a source of overestimation for daily steps
(39). In the current study, steps were underestimated during the 60-min CR session, which is a
departure from the typical pattern of overcounted steps. This could be due to the higher intensity
activity being captured as it normally would, and less time spent in low intensity activity that
may induce false positive step counting.
Few studies have investigated the Apple Watch step estimate error. In a study by Bai et
al. (40), the Apple Watch series 1 was found to overcount Yamax Digiwalker steps by 5% during
an 80 min protocol including sedentary behaviors, light physical activities, and aerobic exercise.
In a separate study, when hand counted steps were compared to the Digiwalker across all
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walking hours of one day, the Digiwalker was found to underestimate steps by 21% (18). The
overestimate found by Bai and colleagues may be interpreted differently if the criterion measure
were hand-counted or SW steps. Veerabhadrappa et al. (41) found the Apple Watch to capture
steps within 5% of hand counted steps for treadmill ambulation of 2, 3, 4, and 5 mph. Although
treadmill walking is symmetric, rhythmic, and continuous, assessing this activity provides insight
about error in step counting across a range of speeds which may help to explain errors in more
ecologically valid assessments.
The strengths of this study were the use of the SW as a criterion as this enabled steps to
be measured across the entire day without video recording and the ability to assess a specific
clinical population (phase II CR). Limitations to this study were the inability to extract minuteby-minute data from the Apple Watch; this precluded the separate analysis for adjusted CR days.
Additionally, it is unknown if participants wore each PAM as reported on the wear time log.
This study provided ecologically valid insights into the error of PAMs for patients
enrolled in phase II CR for days with and without CR and time spent in CR. When errors during
60-min CR sessions were compared to error across the day, the pattern and extent by which steps
were undercounted for all monitors, except for the AGLFE, which were similar to steps across
ACR and NCR days, thereby suggesting that CR does not greatly contribute to error in daily
steps. Given the importance of CR for recovery and secondary prevention of cardiovascular
disease, and the call for innovative home-based or mobile health delivery of CR programs, the
use of consumer-grade PAMs for tracking and setting physical activity goals are a viable option
as the wrist worn consumer monitors showed relatively consistent results when compared to a
healthy population. Because the SW is the most accurate monitor for step counting and to easily
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compare results of future studies, researchers should consider using the SW as the criterion step
count when hand-counted steps through video analysis is not feasible.
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Chapter IV
Using Ecological Momentary Assessment to Explore Anxiety and
Physical Activity for Patients in Phase II Cardiac Rehabilitation
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Abstract
Background: Higher levels of anxiety are a predictor of dropout in outpatient cardiac
rehabilitation (CR) but little is known about the between- and within-person consistency of this
construct or its association with physical activity. Objective: Three aims were to 1. determine
the consistency of state anxiety (SA) across a two week period, 2. investigate the association
between SA and physical activity (PA) between and within participants, and 3. describe the
feasibility of mobile ecological momentary assessment (EMA) with ActiGraph GT3X+
(GT3X+) wear for those in early phase II CR. Methods: Nine adults (33% female, M±SD age:
59.1 ± 8.9 yrs) were recruited. EMA surveys of SA were delivered to participant’s smartphones
four times per day, for 14 consecutive days (total 56 surveys) while they wore a GT3X+ during
all waking hours. An intraclass correlation coefficient was used to describe the SA consistency
across all 56 surveys. Visual assessment of line graphs of SA and scatterplots of SA and PA
across 56 time points were used to describe intra-individual patterns. Feasibility of recruitment,
survey completion, and GT3X+ wear time were assessed. Results: SA scores were low and
consistent. Individual plots showed three patterns in SA across 56 time points and slopes per
participant for the association between PA and SA showed mixed positive and negative results.
Survey compliance rates and GT3X+ wear time met a priori standards, but recruitment rate did
not. Conclusions: EMA data provides the resolution to identify patterns for further subgroup
analysis but recruitment limitations must be addressed.
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Introduction
Cardiovascular disease (CVD) is the leading cause of death in the United States (1) and
world-wide (2). Although the age-adjusted CVD mortality rate has reportedly fallen by a range
of 1.6% to 3.8% per year since 1970 (3-5), CVD continues to account for 30% of all deaths (5).
The monetary cost of CVD in the United States is $200 billion annually (inclusive of
hospitalizations, medications, and productivity loss) (6), and is a leading cause of hospitalization
(7).
For those that have been diagnosed with CVD or who have experienced a cardiovascular
related event or surgery (e.g., myocardial infarction, percutaneous coronary intervention,
coronary artery bypass surgery), participation in cardiac rehabilitation (CR) is recommended by
the American Association of Cardiovascular and Pulmonary Rehabilitation, American Heart
Association, and American College of Cardiology (7). CR is a four-phased exercise and
educational program that begins while the patient is in the hospital, immediately following their
cardiac event or surgery and ends with a maintenance phase of independent exercise. The first
phase consists of hallway walking and activities of daily living to prepare for the transfer from
the hospital to the patient’s home (7). Phase II is a 36-session outpatient program, covered by
insurance, that includes monitored (e.g., blood pressure, continuous ambulatory
electrocardiogram, or heart rate) exercise and educational components aimed to help patients
return to their typical social and vocational activities (7). Phase III is an outpatient program that
is not covered by insurance where patients transition from continuously monitored and directed
exercise sessions to independent exercise. Blood pressure and educational sessions are available,
but the participant selects their own mode of exercise and creates their own exercise schedule
(7). The fourth phase of CR is considered the maintenance phase, where patients create a long-
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term plan for continued independent exercise. Phase IV is not covered by insurance and
monitoring is not offered because this phase usually occurs at home or in an independent
recreational or fitness facility (8).
Completing outpatient CR has many benefits but this program is underutilized. Regular
CR attendance reduces total and cardiac mortality (9, 10) and hospital readmission rates (10),
improves health-related quality of life and modifiable CVD risk factors (9), and increases
perceived physical function scores (11). Regardless of these benefits, 30 to 70% of participants
drop out of CR programs (12). Increased risk for drop out is associated with sociodemographic
and psychological factors. Sociodemographic factors (e.g., being older, female, and having a
lower educational and economic status (12)) require intervention at the policy and health-care
system level and may include items such as providing transportation, home-based programs, or
more flexible hours of attendance (13). Psychological variables related to drop out, such as
anxiety, can be intervened upon and addressed at the person-level within a CR program to
improve overall program attendance and physical activity (PA) levels outside of CR, but such
interventions are needed (12, 14).
Anxiety is described as feelings of concern, worry, or anticipated threats and tension
along with physical characteristics including increased blood pressure, sweating, or heart
palpitations (15). Living with higher levels of anxiety has been associated with the development
of CVD because hypertension, a common physiological outcome of anxiety, is a major
contributor to CVD development (16, 17). Additionally, higher levels of anxiety have been
shown to predict CR drop out within the first two weeks of the program (14). Several validated
scales have been used to survey symptoms of general anxiety that are unrelated to anxiety
disorders. These scales include questions of both state and trait anxiety, which are the two
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dimensions of general anxiety (18). Trait anxiety is a personality characteristic (or trait) that is
stable form day to day, across many situations (19) and state anxiety is typically a momentary
response or temporary feeling (emotional state) of anxiousness that occurs in response to an
experience or situation (19).
In practice and research, general anxiety is typically measured cross-sectionally and is
accepted as a static construct within each individual. For CR programs, a pre-program anxiety
measure is used to refer patients to psychological counselling (7). In research focused on barriers
or correlates of CR non-adherence, summary anxiety scores, determined by averaging the
multiple measures, are used to predict drop out (14, 20). Inter-individual differences in anxiety as
it relates to CR attendance are described; however, single or averaged scores are limited when
attempting to understand the intra-individual differences in decisional processes leading to
repeated occurrence health behaviors (21).
Repeated health behaviors, such as PA, require regular engagement to maintain or
improve overall health. Decisions to complete these behaviors are influenced by experiences,
feelings, contextual elements, and temporal factors across the day (21). Assessing factors
repeatedly over time is critical for capturing changes in those that influence behavior. Entering a
measure of variability of self-efficacy and intention into predictive models were shown to predict
PA better than using static, trait-level individual mean values (22). Thus, although anxiety is a
predictor of CR drop out, temporal variance of state anxiety and its influence on PA engagement
for those in CR are unknown. State anxiety was selected for this study because it has been shown
to be highly variable within and between individuals across occasions on three separate days (23)
but longer-term consistency (across two weeks) is unknown.
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The current study was designed to address this gap by conducting an ecological
momentary assessment (EMA) of state anxiety over two weeks in adults attending early phase II
CR. EMA is a technique for collecting in-the-moment, repeated measures across the time period
where a variable is expected to undulate in the free-living environment, typically using mobile
technology (24). Repeated assessments provide improved resolution of factors and allow for
descriptions of patterns and variability at the individual level, which could help to identify
antecedents of behaviors as they vary from person to person and within one person. When using
EMA to study PA behavior, concurrent use of wearable activity monitors is strongly suggested to
reduce recall bias associated with self-reported PA and to capture subconscious activity, such as
short walking bouts to complete tasks at work or during activities within the home (25). This
study has three aims: 1. to determine the consistency of state anxiety across 56 time points over a
two week period, 2. to investigate the association between state anxiety and subsequent step
counts between and within participants, and 3. to describe the feasibility of mobile EMA while
wearing an ActiGraph GT3X+ (GT3X+) for those in early phase II CR.
Methods
Study Design
Individuals within the first three weeks, or nine sessions, of phase II CR were recruited
for this study. Consenting participants received four mobile EMA survey links per day that were
delivered to their smartphones via SMS (short message service), at four predetermined times, for
14 consecutive days. Participants were encouraged to answer the surveys within 60 min of
receipt in order to capture a measure of momentary state anxiety. Participants concurrently were
asked to wear the GT3X+ on their waist during all waking hours of each day.
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Participants and Recruitment
Adult participants between 18 and 80 years of age were recruited from the phase II
cardiac rehabilitation program at the Heart Lung Vascular Institute of the University of
Tennessee Medical Center in Knoxville, TN. Exclusionary criteria included individuals who did
not own a smartphone or have access to a data plan, previously completed a CR program, had
been enrolled in CR longer than three weeks, had an ejection fraction <35%, were diagnosed
with pulmonary disease and/or diseases that are related to cognitive decline or memory
impairment, required an assistive device for ambulation, or were referred to CR following
valvular surgery or heart transplant. The research protocol was approved by the University of
Tennessee Graduate School of Medicine and the University of Tennessee, Knoxville Institutional
Review Boards. All participants provided written informed consent before participating in this
study.
Rolling recruitment was completed with a two-step process over a four-month time
period (February to June 2019). First, CR nurses and exercise physiologists reviewed the healthrelated exclusionary criteria (i.e., age, ejection fraction <35%, diagnosed with pulmonary disease
and/or diseases that are related to cognitive decline or memory impairment, and referred to CR
following valvular surgery or heart transplant) for each new patient entering the CR program to
determine eligibility. Eligible patients were then referred to the researcher. In the second step of
recruitment, the researcher individually approached each referred participant at their CR session
and determined if they were eligible based on the need of assistive walking device and
smartphone ownership. For those who remained eligible, the researcher explained the study and
participation requirements. Each enrolled participant provided written, informed consent.
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Protocol
Enrolled participants met the researcher at the subsequent CR session to receive and
complete a mock survey to determine smartphone capabilities, to provide clarification, and to
address questions or concerns. At this time, participants were reminded to answer surveys within
60 min of receipt for the duration of the study. Each participant was then provided a GT3X+ and
log to record when the monitor was worn and they were shown how to use both. The GT3X+
monitors were attached to an elastic belt and the monitor was positioned over the right hip.
Participants were asked to wear the GT3X+ during all waking hours, except during water
activities, during each of the 14 survey days.
Following the mock survey session, the researcher programmed mobile survey
distribution for the following 14-day period. Surveys were programmed for delivery four times
per day (07:45, 11:45, 15:45, and 19:45), every day, for two consecutive weeks. Survey links
were delivered via SMS to the participant’s mobile phone. By tapping on the active link, the
survey opened in the primary web browser on the participant’s mobile phone, enabling them to
report in-the-moment state anxiety. Survey results and metadata (e.g., time of day surveys were
opened and duration of time between when the survey was opened to completion) were
automatically stored upon survey completion.
Instrumentation
Mobile surveys. Qualtrics Research Core (Qualtrics, Provo, UT) was used to create,
deliver, collect, and store survey results and metadata. It is a research platform that allows users
to create surveys by means of point and click choices, providing an array of response options
(e.g., sliding scale, multiple choice, matrix table) enabling the researcher to choose response
types that suit their question and intended statistical analyses. Several benefits of the Qualtrics
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platform are the options for delivery of surveys, ease of survey completion for participants, and
data storage and security (26).
Spielberger State-Trait Anxiety Inventory (STAI) Short Form. The original STAI is a
40-item inventory consisting of 20 items related to state anxiety and 20 items related to trait
anxiety. The state and trait inventories are scored separately, providing a measure for each
construct (27). A short form of the state anxiety inventory was developed using six items from
the original form to reduce participant burden when brevity was necessary. The short and
original form yield state anxiety scores that are highly correlated (r = .95) (28). Additionally, it
has been validated in several clinical and non-clinical populations such as those who are
critically ill or on ventilatory support (29), previous myocardial infarction (30), respiratory
patients (31), new parents to infants with and without abnormal newborn screens (32), and
nursing and medical students (28).
Each STAI short form item is scored with a four-point Likert scale. For items that
indicate the presence of anxiety (e.g., “I am tense” or “I feel upset”), a rating of four indicated a
high level of anxiety. For the other items, (e.g., “I am relaxed” or “I feel content”), a rating of
four indicates the absence of anxiety (19). After the scores for the anxiety-absent items were
reversed, all scores from each STAI short form item were summed to create a total score which
ranged from 6 to 24. Higher total scores represent higher levels of state-anxiety.
ActiGraph GT3X+. The GT3X+ activity monitor (4.6 × 3.3 × 1.5 cm, 19g) was used to
assess PA. GT3X+ monitors include a triaxial accelerometer that measures raw accelerations in a
range of ± 6 G. Sampling frequency is determined by the user at a rate between 30 and 100 Hz
during monitor initialization. Raw acceleration data is stored on the internal memory of the
monitor until it is downloaded (33).
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GT3X+ monitors were initialized to sample data at 30 Hz using the ActiLife software (v.
6.13.3, ActiGraph LLC, Pensacola, FL), distributed to participants, and worn during the 14-day
study. When initialized at 30 Hz, the battery life and memory limit are 31 and 42.5 days (33),
respectively, so participants were able to wear the same monitor for the duration of the study.
After completing the protocol, GT3X+ monitors were collected then acceleration data were
downloaded and converted to activity counts using the ActiLife software without the low
frequency extension enabled. Count data for each participant were then processed with the
ActiLife Wear Time Validation tool using the Choi Algorithm to establish GT3X+ wear time for
each participant. Next, using the Global Time Filters on the Scoring tab within ActiLife, steps
were summed during periods of Choi validated wear time across the four hours following
surveys (07:45 to 11:45, 11:46 to 15:45, and 15:46 to 19:45). This process provided the step
count and the minutes of valid wear time across the given four-hour block. Some participants did
not wear the GT3X+ for the total duration of each four-hour block so total steps for the four-hour
time period were scaled to steps per hour. Steps per hour were calculated by first dividing the
steps per four-hour block by minutes of wear time for the given block and then multiplying that
value by 60. This step was important so comparisons could be made using the same unit of PA,
therefore, individuals who provided more wear time did not unfairly weight the sample.
Data Processing
Mobile survey data. Mobile survey responses and metadata were downloaded from the
Qualtrics platform in separate comma separated values files for each survey delivery time.
Metadata (i.e., survey start date and time, end date and time, recorded date and time, survey
duration, and recipient identification name), STAI short form responses, and step count per hour
were entered into an Excel database. The STAI short form responses were summed in this
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database to produce the state anxiety score. Each state anxiety score was labeled for its time
block denoting the time of delivery where T1, T2, T3, and T4 represented 07:45, 11:45, 15:45,
and 19:45, respectively, and were labeled sequentially (1 through 56) for time course analysis.
When step counts per hour were entered into the database, they were aligned with the survey
delivered at the beginning of the four-hour block that was used to calculate steps per hour (e.g.,
the step count per hour aligned with the 07:45 survey represented step per hour from 07:45 to
11:45). Data were visually inspected to remove all mock survey responses, identify missing data,
and flag responses that were completed more than 60 minutes following survey receipt. The
following shows the number of missing PA or state anxiety scores data points and the number of
state anxiety scores removed for survey completion >60 minutes following receipt:
•

07:45: 10 missing, 20 removed;

•

11:45: 8 missing, 13 removed;

•

15:45: 17 missing, 10 removed; and

•

19:45: 9 missing, 10 removed.

Further data management is discussed for each separate analysis.
Data Analyses. Separate analyses for state anxiety consistency, association between state
anxiety and PA, and mobile EMA feasibility were completed to address each purpose of this
study.
The first aim was to determine the consistency of state anxiety across 56 time points over
a two-week period. Consistency of state anxiety was assessed by determining an intraclass
correlation coefficient (ICC) across all 56 time points for each participant. For this analysis,
missing state anxiety scores (44 missing out of a possible 504 scores) were imputed using the
participant’s mean state anxiety score for the corresponding day. Cicchetti interpretations for
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ICCs were used to describe the level of consistency; < 0.40 = poor, 0.40 to 0.59 = fair, 0.60 to
0.74 = good, and 0.75 to 1.00 = excellent (34). Standard deviations of state anxiety for each
participant were also included as a measure of individual variability and figures showing state
anxiety scores across each survey (56 time points) were created. Descriptive statistics were
completed with SPSS Version 25 for Windows, (SPSS Inc., Chicago, IL).
Aim two was to investigate the association between state anxiety and subsequent step
counts between and within participants. Scatterplots with linear trendlines along with linear
regressions were used to assess the direction and strength of the association between PA and
state anxiety score and to determine if repeated measures analysis (rmcorr) could be used to
assess associations while accounting for time-dependent data within individuals. Linear
regression was only used to determine if slopes were positive or negative and correlation
coefficients should be interpreted with caution because repeated assessments violates the
assumption of independence of observations. Strength of association was not assessed. No data
were imputed for missing values and entries that were completed more than 60 min after receipt
were also removed from this analysis to avoid convoluting the temporal sequence of momentary
anxiety score to PA across the following four hours. Entries with missing data for state anxiety
score or step count per hour were not included in the scatterplots. State anxiety scores were
entered on the x-axis and steps per hour were entered on the y-axis. State anxiety was explored
as a predictive variable to PA because a strong association between high state anxiety and low
PA would indicate state anxiety to be an important component for intervention.
The third aim was to describe the feasibility of mobile EMA with GT3X+ wear for those
in early phase II CR. Specifically, feasibility for recruitment, survey completion rates, and
GT3X+ wear time were assessed using a priori benchmarks. The a priori benchmark for
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recruitment was set at one participant per week which was based upon estimated phase II CR
program recruitment of zero to six patients per week. A survey completion rate of 75% within 60
minutes of receipt was set because if one survey was missed, temporal associations could be
preserved with at least one morning and one afternoon measurement. A 60-minute survey
response time was used to maintain temporal sequence between momentary measurement of
state anxiety and the PA outcome. Finally, 10 hours of GT3X+ wear time was set as the a priori
benchmark as it is a commonly accepted wear time benchmark (35) and should allow for capture
of activity across a large proportion of the time surveyed, however the limitations of this
benchmark are discussed.
Results
Participant Characteristics. Of the 53 (18 women, 35 men) new CR participants during
four months of recruitment, 25 (6 women, 19 men) were eligible and approached for recruitment.
Of those individuals, nine participants (33% female, mean ± SD age, 59.1 ± 8.9 yr) were enrolled
in this study (Table 3).
Consistency of state anxiety. The average state anxiety score across the 14-day period
was 9.1 on a scale of 6 to 24 (Figure 3). Across all 56 time points, consistency of reported
anxiety was considered good (ICC = 0.68, 95% CI: 0.49 – 0.89, P < 0.01). One participant
completed all surveys, four participants had one imputed score, three participants had between
three and 10 imputed scores, and one participant had 19 imputed scores.
Figure 4 shows examples depicting anxiety scores at each time point. Three emerging
patterns in state anxiety scores were a high intra-individual consistency with an individual mean
lower than the grand mean, greater intra-individual variation with individual mean higher than
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Table 3. Summary of participant characteristics.
All (N = 9)

Women (n = 3)

Men (n = 6)

Age (yr)

59 ± 9

63 ± 4

57 ± 11

Height (cm)

173.6 ± 10.5

160.9 ± 3.9

179.9 ± 6.9

Weight (kg)

93.4 ± 9.5

96.4 ± 11.5

92.0 ± 10.1

BMI (kg/m2)

31.3 ± 4.9

37.2 ± 3.6

28.4 ± 2.7

MI: 1

MI: 1

MI: 0

Stent: 3

Stent: 0

Stent: 3

MI and Stent: 2

MI and Stent: 1

MI and Stent: 1

CABG: 3

CABG: 1

CABG: 2

Reason for CR
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Figure 3. Mean and standard deviation of state anxiety scores across two weeks, for each
participant. Dashed horizontal line represents the grand mean anxiety score for all participants.
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Figure 4. Three emerging patterns of state anxiety across all 56 survey time points. A. high intraindividual consistency with an individual mean lower than the grand mean, B. greater intraindividual variation with individual mean higher than the grand mean, and C. a tapered effect
greater state anxiety variability during the first week but became highly consistent during the
second week.
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the grand mean, and a tapered effect showing greater variability in state anxiety during the first
week that became more consistent during the second week.
Association of state anxiety and PA. A scatterplot of all participant state anxiety and PA data
showed a negative slope (β = -25.5, r = -.264) between state anxiety and the steps per hour across
the hours following the anxiety measure (Figure 5). Figure 6 shows scatterplots for each
participant with linear trendlines. Slopes and correlation coefficients show three positive slopes
and six negative slopes for individual participants, which were used to determine that due to the
mixed directions of the slopes, rmcorr could not be utilized because this method of analysis
requires slopes of the same direction (36).
Feasibility of mobile EMA with GT3X+ wear. For recruitment, the a priori benchmark
of enrolling one participant each week was not met since only nine participants were recruited
across a four-month period. Of eligible participants, only 36% consented and were enrolled in
this study (Figure 7).
Of the total 504 surveys distributed, 91.3% were completed, with individual participants
completing a range of 66 to 100% of the surveys distributed to them. On average, participants
completed each survey in 3.9 min and surveys were returned 29±42 min after receipt. The a
priori benchmark of completing at least 75% of surveys within 60 min of receipt was met; in
total 85% of surveys were completed within 60 min. Survey compliance at each time point was
as follows: 07:45, 75%; 11:45, 84%; 15:45, 70%; and 19:45, 83%.
Average Choi Algorithm determined GT3X+ wear time was 10.3±2.7 hr per day (range:
0.1 to 14.5 hr per day), which met the a priori benchmark for valid wear time (10 hrs per day).
During the 12 hours of interest that corresponded to survey delivery (07:45 to 19:45), only 27%
of days resulted in 12 hours of accelerometer data.
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Figure 5. Physical activity as a function of state anxiety score for all participants across all
survey time points.
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Figure 6. Physical activity as a function of state anxiety scores inclusive of all non-missing data points for each participant across all
survey time points.
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Figure 7. Recruitment and enrollment flow chart detailing all new patients, eligible patients, number who enrolled, and reasons
eligible individuals did not enroll.
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Before the first day of participation, all 56 surveys per participant were scheduled for
delivery. This process took approximately one hour per participant. If two or more participants
were beginning on the same day, their surveys could be scheduled at the same time, therefore
reducing administrator burden as two or more participants could be scheduled in the same
amount of time that one participant could be scheduled. For this study, approximately 7 hours
were spent scheduling survey delivery. Preparing, downloading and processing, and analyzing
accelerometer data and step count output required minimal time (5 min, 8 min, and 30 min,
respectively) and in total, the time spent was about 6.5 hrs. Relatively little time was spent faceto-face with each participant, with the majority of this time being spent navigating through the
sample survey and explaining proper accelerometer wear (approximately 15 min). Total time
spent face to face was about 2.3 hrs. The total administrator time burden for delivery, download,
and training was 15.8 hrs.
Discussion
Participants in this study had relatively low and consistent state anxiety scores across the
14-day study according to ICC and average state anxiety results. When all participant data were
included on one scatterplot with a linear trendline showing the steps per hour as a function of
state anxiety, the negative slope suggests higher state anxiety is followed by a period of fewer
steps per hour. Upon further inspection of scatterplots created for each participant, three positive
and six negative slopes were found, thereby showing inconsistent between-person associations
between PA and state anxiety. Because the directionality of individually plotted slopes differed,
it is likely that a direct individual-level association between PA and state anxiety does not exist
or other factors are confounding the relationship. Feasibility of mobile EMA and activity monitor
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wear was also assessed in this study. Briefly, the a priori benchmark for survey completion and
GT3X+ wear time were met, however, recruitment rate was not.
As compared to similar populations, state anxiety scores in the current sample were low.
To compare state anxiety scores from this study to the percentile norms shown in the original
State Trait Anxiety Inventory, results were multiplied by 3.3. This adjustment was determined by
dividing the lowest score from the original form by the lowest score for the short form which
provided the adjustment factor. The risk of inflation of scores and variance due to extreme scores
should be considered when prorating sub-scales or short forms (37). After prorating the short
form mean state anxiety score (9.1 × 3.3 = 30.0), participants fell in the 40th to 47th percentiles
for similarly aged individuals (50-69 yrs) (27). Because 88% of individuals received some type
of cardiac-related surgical intervention (i.e., stent placement or bypass surgery), state anxiety
scores were also compared to percentile ranks for general medical and surgical patients. On
average, general medical and surgical patients had higher mean state anxiety scores than the
current sample, 42.4 vs 30.0, respectively, and fell in the 21st percentile rank. When compared to
a larger sample of CR attendees, the current sample showed a slightly lower mean state anxiety
score (32.1 larger CR sample vs 30.0 current sample) (38). In comparison to other populations
which used the short form state anxiety inventory, the current sample, with an average score of
9.1, scored slightly greater than pregnant women (8.7), student nurses (7.0), and medical students
(6.7) (32).
The consistency of state anxiety in this population could be related to the frequency of
low state anxiety scores. Consistency, measured with ICCs across all 56 time points (ICC =
0.68), was “good” using the Cicchetti interpretations (34). These interpretations, however, were
developed to assess inter-rater agreement, not consistency in repeated behavioral construct
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measures across one participant. Therefore, application of ICCs in this study are somewhat
limited but have been previously used to describe consistency in similar repeated intra-individual
assessments (39). Scores with high frequencies may also contribute to consistency. Among all of
the results, the most frequently reported state anxiety score was 6, accounting for 137 out of 407
(33.7%) total responses. The clustering of this score indicates a floor effect, thereby suggesting
the STAI short form may not have the resolution necessary to measure state anxiety for those
who generally experience low state anxiety.
Exploring measures of variability, not only average-level data, is suggested to account for
the dynamic nature of emotions, feelings, and constructs one experiences throughout the day
(21). Entering a value representing instability, such as standard deviation, of factors that
naturally fluctuate have provided meaningful outcomes in describing relationships between
variables above that of mean-level data. Gerstorf et al. (23) assessed the variability of state
anxiety across three occasions during an 11-day span in adults using standardized standard
deviations. This sample, on average, reported low mean state anxiety scores, but 94% of the
sample showed variability in scores across the three assessment points. The authors note that
individual variance was patterned asymmetrically around the mean and should be considered a
source of information when investigating correlates with predictive modeling.
For constructs that do fluctuate throughout the day, accounting for variability has been
shown to predict PA outcomes more strongly than mean-level data. Dunton et al. (40) found that
a higher level of stability in positive and negative affect in children was significantly related to
higher levels of moderate to vigorous PA; previous research showed no relation between mean
levels of affect and PA. Additionally, Pickering et al. (22) showed that while individual-level
means for self-efficacy and intention were unrelated to moderate to vigorous PA, entering a
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measure of instability for both of these constructs demonstrated that the greater instability was
related to higher amounts of moderate to vigorous PA. These findings indicate that measures of
instability should be considered for within-individual predictive models.
Visually exploring the landscape of data is a unique opportunity to identify emerging
patterns within the data. To further explore the within-person patterns of anxiety score,
individual line graphs for each participant were created including each survey time point (56
instances) plotted across the x-axis and state anxiety scores plotted along the y-axis were created.
Three identifiable patterns emerged from inspecting these graphs and a spike in anxiety was
easily identifiable during an anecdotal, state anxiety inducing event. The emerging patterns
showed that some participants appeared to have higher levels of score consistency with
individual means lower than the grand mean; some showed more instability with individual
means higher than the grand mean and one participant showed a tapered effect where state
anxiety was more variable during the first than the second week. In larger studies, if these
patterns recur, associations between CR attendance or level of PA engagement should be
investigated similar to that in weight loss research. Three classifications of weight loss patterns,
modest, moderate and steady, and substantial and early, have been identified through studying
variance in individual weight loss patterns and weight loss predictor variables (e.g., PA, social
support, psychosocial variables) differ among each classification (41). Identifying homogeneous
subgroups has provided weight loss researchers with a classification scheme and specific area for
intervention that are tailored per each subgroup to improve interventions.
Visually assessing individual slopes can also guide investigators toward appropriate
statistical treatments. A recently developed approach for investigated associations between
variables for repeated measures data is rmcorr. This was appealing because traditional linear
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regression or correlation methods assume independent observations, which was violated by the
repeated measures within each individual. Although linear regression was used in this study, it
was only to assess the direction of the slope for the association between PA and state anxiety, it
was not used to determine significant relationships. Non-independence is accounted for in rmcorr
by statistically adjusting for inter-individual variance, allowing for common intra-individual
variance to be assessed. In this technique, a common slope is fit to each participant with
individual intercepts and the rmcorr coefficient represents the strength of the linear association
(36). However, for this data rmcorr was not appropriate because all slopes must be in the same
direction and in this sample, they are not.
The varied slope directionality and weak associations may be a result of state anxiety
assessment inventory or the selected metric of PA. The floor effect elicited from the state anxiety
short form indicates that this scale may be inappropriate for individuals with low anxiety. Visual
analogue scales have been validated for the assessment of anxiety and therefore could be
considered for future use to gain a measure of anxiety across a spectrum of 0 to 100 (42). The PA
metric of steps is a possible limitation to this study. The total volume of PA as measured by steps
may be inappropriate because step counts included in this analysis captured both exercise and
activities of daily living. Steps taken during work or home-based activities may be completed
regardless of one’s level of state anxiety because these steps are associated with obligations of
life. Therefore, it is possible that anxiety is more related exercise activity and a measure of
moderate to vigorous activity would be more appropriate. Also, the time span in which steps
were investigated (across four hours) may be too long of a duration to pair with momentary state
anxiety. The frequency in which state anxiety fluctuates remains unknown but higher resolution
data can inform the appropriate time comparison.
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The final purpose of this study was to assess feasibility of mobile EMA in terms of
recruitment, survey compliance, and GT3X+ wear time for those in early phase II CR. The
largest challenges to recruitment were smartphone ownership, interference with careers, and low
numbers of women enrolled in CR. Findings of a recent Pew Research Center report show that as
of 2019, 81% of all Americans own a smartphone which is reduced to 79% for those 50-64 years
and 53% of those 65 and older (43). The decline in ownership with increasing age is important
for researchers to consider when the target population is typically older. Future studies could
consider providing easy-to-use smartphones to their participants. The other most commonly
occurring reason for non-participation was interference with their career. According to the
Bureau of Labor Statistics, full-time employed individuals are at work for 8.5 hours on week
days (44), which accounts for 68% of waking hours, assuming 8 hours of sleep. Being unable to
capture momentary assessments during this time not only provides an incomplete picture for the
participant but also prevents momentary assessment of topics such as workplace related anxiety
and stress. A consideration is to utilize passive measurements of biological markers such as
cortisol or heart rate variability to capture stress, but user input of context and experiences would
be a limitation. Additionally, survey delivery before and after work hours could be employed;
however, individualizing survey distribution schedules for each participant will increase
administrator burden.
In the current study, only 33% of the participants were women which is not surprising
given women are an underrepresented group in outpatient CR. Participation rates of women
range from 15 to 20% as compared to 25 to 31% for men (12). Clinicians and physicians more
often refer men than women to CR programs and this same bias has also been found for older
adults and ethnic minorities (45). Additionally, women often hold caregiving roles and tend to
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report more feelings that exercise is not important for them or they express that is it
uncomfortable exercising around men (12).
Earlier studies have demonstrated that mobile surveys, as opposed to paper and pencil
surveys, have higher compliance rates, 96% vs 70%, for young adults (46) with mobile versus
paper and pencil surveys. Although mobile technology such as smartphones are becoming
increasingly ubiquitous, compliance in middle-aged to older adults must be assessed. Ehlers,
Huberty (39) assessed the mobile survey compliance of female adults aged 46±8 yrs receiving
two to three mobile surveys per day and found high compliance, with the women completing
91.1% of the surveys delivered within 2.5 hrs of receipt. These findings are similar to that of the
current study where the average age of the participants was 59.1 yrs and 85% of surveys were
completed within 60 min of receipt. Of note, during this study there was one instance of late
survey delivery (affecting three participants). This error was due to Qualtrics server malfunction,
which the researcher confirmed by calling the Qualtrics help desk. These surveys were delivered
approximately 60 min late which caused removal of these responses from the association
analysis. Requiring survey response within 60 minutes helped to maintain the temporal
association between anxiety score and subsequent steps per hour. Because both EMA responses
and PA measures are time stamped, the late responses could be paired with the correct measure
of PA, however, statistical methods in predictive modeling, like multi-level modeling, are robust
to missing data, therefore, reducing administrator burden.
Wearable activity monitors are suggested for use with EMA of PA to gain an objective
measure of activity (25). A benefit of utilizing activity monitors is the ability to capture light
activity that is often completed subconsciously and is often under-reported or not assessed in
validated self-report methods (47). Compliance with GT3X+ wear met the a priori benchmark
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for feasibility. This benchmark was selected because of its widespread use but researchers should
consider their study design and the wear time required to capture the time periods surveyed. For
this study, 12 hours of wear time, specifically 07:45 to 19:45, would have adequately captured
the times corresponding to survey delivery and steps per hour across the four subsequent hours.
Only 27% of days in this sample showed valid GT3X+ wear time during the 12-hour block of
interest. To account for missing time and to provide an evenly weighted metric across all
participants, a scaled measure of PA, steps per hour, was utilized. Other studies have employed
24-hour monitoring protocols on the waist and the wrist, both showing excellent compliance with
waist wear of 22.6 hr/day (48) and wrist wear of 23.9 hr/day (39).
To date there has only been one other EMA in a population of those diagnosed with
CVD. Rosmalen et al. (49) analyzed the causal relationship between depression and PA in five
men post-myocardial infarction. PA and depression were assessed once per day for three months.
Vector autoregressive modeling was used to assess temporal changes in the variables of interest
and made causal inferences about the dynamics between depression and PA. Although this
sample was small, analysis of individual participants showed evidence that PA preceded
depression and in others, depression preceded PA. As noted by the challenges experienced in
recruiting for the current study, small samples are expected for EMA of clinical populations.
This study offered novel findings in a clinical population, but several limitations must be
noted. First the findings of this study may not be generalizable to females due to the small
sample of women. Because participants were required to own a smartphone, those of low
socioeconomic status could not participate, and therefore the results may not apply to them.
Additionally, those with higher state anxiety levels were not captured in this sample. Selecting
steps per hour was a limitation as this value includes obligatory steps that are taken regardless of
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anxiety level, therefore, entering the optional moderate and vigorous activity may yield different
results.
This was the first study to explore the consistency and patterns in state anxiety and to
investigate its relationship with PA, several times per day, across a 14-day period. Assessing the
temporal patterns and associations at the mean and individual levels are aligned with the first
phase of intervention development outlined by the Obesity-Related Behavioral Intervention
Trial, which requires defining and refining variables for intervention development (50).
However, to capture this data, challenges to recruitment and the accessibility of participating in
EMA-type studies must be addressed.
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Chapter V
Conclusion
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In part one of this two-part dissertation, the step count error of several physical activity
monitors (PAMs) was assessed for those in phase II cardiac rehabilitation (CR). Analyzing step
counting error across the day provides researchers insight on monitor function in an ecologically
valid setting and it may guide users to a monitor better suited to their intended population. Part
two is an exploration of state anxiety and physical activity using ecological momentary
assessment (EMA) with ActiGraph wear across 14 days for patients in early phase II CR. Part
two had three aims: 1. to investigate the consistency of state anxiety, 2. to explore the association
between state anxiety and physical activity, 3. to determine the feasibility of a 14-day EMA of
state anxiety and physical activity delivered via smartphone.
In the first study, step count error for the Fitbit Charge 2, Fitbit Zip, Apple Watch Series
2, ActiGraph GT9X with and without the low-frequency extension enabled and processed with
the moving average vector magnitude algorithm was assessed on days when participants attended
CR, days when they attended CR with steps taken during CR were removed, and days when they
did not attend CR. Additionally, step error was assessed during CR sessions. Overall, monitors
tended to underestimate steps and the Fitbit Charge and Apple Watch monitors showed the least
step counting error for each condition when compared to criterion (StepWatch) steps. Error rates
during CR sessions were similar to that during the day, therefore suggesting that CR activities do
not intensify step counting error. Assessing the error in wearable activity monitors in clinical
populations is warranted as these devices are becoming increasingly popular in healthcare and
mobile health interventions.
Study two was the first study to explore intra- and inter-individual patterns in state
anxiety and the association between state anxiety and physical activity during early phase II CR
using ecological momentary assessment. Although this sample had relatively low and consistent
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state anxiety, three patterns of anxiety emerged and, interestingly, the individual associations of
state anxiety and physical activity varied across the sample, with some participants showing
positive and some showing negative relationships. Assessing temporal and associative patterns
enables defining and refining variables for intervention development. However, improving the
accessibility to and recruitment for this type of study must be addressed.
When utilizing ecological momentary assessment to investigate physical activity, use of
an objective physical activity monitor has been recommended. Taken together, the first study
assessed the step counting error of several activity monitors that could be used along with an
ecological momentary assessment and in the second study, the activity monitor was implemented
and specifics on wear time and activity metrics were discussed. Ecological momentary
assessment of self-reported data and objectively assessed data are well suited for use
concurrently in order to capture all physical activity objectively while using momentary
assessments to define contextual information as well as feelings and other experiences associated
with that same period of time.
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Consent to Take Part in a Research Study

Title: Accuracy of Wearable Step Counters for Patients in Phase II Cardiac
Rehabilitation
Principal Investigator: Lindsay Toth, M.S.
The purpose of this study is to determine if the step count displayed on wearable physical activity
monitors is accurate for people in phase II cardiac rehabilitation. Participants will wear three
physical activity monitors (one on their wrist, one on their waist, and one on their ankle) for five
days, from the time they wake up, until the time the go to sleep. Participants will be asked to
write down the step counts from some of the monitors in the morning and the evening. The total
study duration is six days. The greatest risk of this study includes a loss of confidentiality.
If you are interested in learning more about this study, please continue reading below.
You are being asked to take part in a research study. This information is provided to tell you
about the study. Please read this form carefully. Your participation is voluntary. Saying no will
not affect your rights to health care or services. You are also free to withdraw from this study at
any time.
What is the purpose of the study?
The purpose of the study is to determine the step count accuracy of four wearable physical
activity monitors as compared to the StepWatch Activity monitor (step counting gold standard).

How long will I be in the study?
You will be in the study for six days.

Initials of Consentee
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What will happen to me during the study?
The following tests or procedures that are required in this study for research purposes are:
• Day 1
o Height and weight will be measured
o You will be shown how to wear the physical activity monitors and how to record
step counts
• Days 2-6
o You will wear the physical activity monitors (one on your wrist, one on your
waist, and one on your ankle) from the time you wake up in the morning until
the time when go to sleep at night
▪ You will record the step counts from some of the monitors in the
morning and at night
▪ You will be asked to remove the devices any time you come into
contact with water (e.g., swimming or bathing)
What side effects or risks can I expect from being in the study?
The potential risks to you include:
a) Physical activity monitors emit electromagnetic radio waves that can temporarily inhibit
a single beat from pacemakers, but the pacemaker’s regular signals are quickly restored
when the activity monitor is moved away from the pacemaker according to the American
Heart Association. Physical activity monitors fall under the category of consumer
appliances and electronics that pose little to no risk for individuals with cardiac
pacemakers. They should be kept at least six inches away from a pacemaker.
b) A risk of participating in this study is a loss of confidentiality. To reduce the risk of this
violation, each participant will be assigned a number. Only the PI will know the number
associated with each participant. All signed informed consent documents and data sheets
will be stored in separate locked file cabinets. Informed consent documents will be store
in a locked file cabinet in the Applied Physiology Laboratory in the Health, Physical
Education, and Recreation Building in room 317. All data sheets will be stored in a locked
file cabinet in the Applied Physiology Laboratory in the Health, Physical Education, and
Recreation Building in room 303. Informed consent documents and data sheets will be
kept for three (3) years after the study has been completed.
Are there benefits to taking part in the study?
The potential benefit includes:
a) The possible benefits to society may improve scientific knowledge concerning the
relationships between state-anxiety, core affect, fatigue, self-efficacy, and intentions as
they relate to physical activity during phase II cardiac rehabilitation. This information
may be used to guide future cardiac rehabilitation interventions better promote continued
attendance and participation.

Initials of Consentee
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What other choices do I have if I do not take part in this study?
If you do not choose to take part in this study, you will complete phase II cardiac rehabilitation
as ordered by your physician.

How many people will be in the study?
About 60 people will be in this study at UT Medical Center (UTMC).
What will it cost me to be in the study?
There are no costs to you or your insurance for taking part in this study.
Will I be paid for taking part?
You will not be paid for taking part in this study.
Is the Investigator paid to do this study?
No, the investigator is not being paid to enroll people in this study.
What if I am injured in this study?
You will get medical treatment if you are injured as a result of taking part in this study. You
and/or your health plan will be charged for this treatment. The study will not pay for medical
treatment.
It is important that you tell your study leader, Lindsay Toth, if you feel that you have been injured
because of taking part in this study. You can tell her in person or call her at 412600-4342. You
may also tell your doctor if you feel you have been injured because of taking part in this study.
You are not waiving any legal rights or releasing the University of Tennessee or its agents from
liability for negligence. In the event of physical injury resulting from research procedures the
University of Tennessee does not have funds budgeted for compensation either for lost wages
or for medical treatment.
In the case of injury resulting from this study, you do not lose any of your legal rights to seek
payment by signing this form.
Who do I call if I have questions about the study?
Questions about the study:
Lindsay Toth,
M.S.
Phone: 412600-4342
Email: Ltoth2@vols.utk.edu
Questions about your rights as a research subject: You may contact the UT Graduate School of
Medicine Institutional Review Board (IRB) at 865-305-9781. The IRB is a group of people that
reviews studies for safety and to protect the rights of study subjects.
Initials of Consentee
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Can I stop being in the study?
You may withdraw from the study at any time. Your treatment, payment or enroll ment in any
health plans or eligibility for benefits will not be affected if you decide not to take part.
Could I be removed from the study?
You may be withdrawn for the study for any of the following reasons:
▪ You are unable to wear the physical activity monitors
▪ You are unable to read the screen of the activity monitors
Identifiable private information or identifiable biospecimens:
Identifiers might be removed from the identifiable private information and after such removal, the
information could be used for future research studies or distributed to another investigator for
future research studies without additional informed consent from you or your legally authorized
representative.
CONSENT OF SUBJECT:
I have read or have had read to me the description of the research study. The investigator or
his/her representative has explained the study to me and has answered all of the questions I have
at this time. I have been told of the potential risks, discomforts and side effects as well as the
possible benefits (if any) of the study. I will receive a copy of this form after it is signed.
I freely volunteer to take part in this study.

Printed Name of Subject

Signature of Subject or
Authorized
Representative

Date & Time

Printed name of person
Obtaining Consent

Signature of person
Obtaining Consent

Date

Printed name of Investigator

Signature of Investigator

Date

Initials of Consentee
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Consent to Take Part in a Research Study

Title: Ecological Momentary Assessment of Affective and Cognitive Factors
Related to Total Physical Activity in Early Phase II Cardiac Rehabilitation
Patients
Principal Investigator: Lindsay Toth, M.S.
The purpose of this research study is to investigate how your feelings and perceptions are related
to your daily physical activity level and how they change across your first few weeks in phase
II cardiac rehabilitation, for individuals who are engaging in cardiac rehabilitation for the first
time. Participants will undergo a brief screening consisting of one questionnaire, measurement
of height at weight, they will be shown how to use and enter responses for the surveys used in
this study, and how to wear the physical activity monitor. This visit will take approximately 40
minutes. Participants in this study will be asked to complete four surveys sent to their
smartphones each day, for 14 consecutive days. Each survey can be completed in less than 5
minutes. Participants will be asked to wear a non-invasive physical activity monitor on their
waist for those same 14 days and complete a log of when they put the monitor on in the morning
and took it off at night. During the period of participation, participants are only asked to answer
surveys and wear an activity monitor while maintaining their usual behavior. No additional
lifestyle changes are requested. When the 14-day participation period is over, the physical
activity monitor and log will be collected from the participants. Total study duration is 16 days.
The greatest risk of this study is the loss of confidentiality.
If you are interested in learning more about this study, please continue reading below.
What is the purpose of the study?
The purpose of the study is to investigate if there are certain feelings and perceptions that are
associated with engagement in daily physical activity for those who are enrolled in phase II
cardiac rehabilitation for the first time.
How long will I be in the study?
You will be in the study for 16 days.
What will happen to me during the study?
The following tests or procedures that are required in this study for research purposes are:
• Day 1
o Height and weight will be measured one time
o You will be shown how to use the electronic survey and how to enter your
responses
Initials of Consentee
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•

•

o You will be shown how to wear the physical activity monitor on your waist and
how to complete the wear-time log
Days 2-15
o You will put on the physical activity monitor in the morning when you wake up
and wear it throughout the day, until you go to sleep at night
▪ You will record the time you put the monitor on in the morning and what
time you take the monitor off at night on the wear-time log
o You will receive a text message at 7:45am, 11:45am, 3:45pm, and 7:45pm that
contains a link to a survey
o You will tap on the link and complete the survey within one hour of receiving
the text message
Day 16
o You will return the physical activity monitor and wear-time log

What side effects or risks can I expect from being in the study?
The potential risks to you include.
a) ActiGraph GT3X physical activity monitors emit electromagnetic radio waves that can
temporarily inhibit a single beat from pacemakers, but the pacemaker’s regular signals
are quickly restored when the activity tracker is moved away from the pacemaker
according to the American Heart Association. Physical activity monitors fall under the
category of consumer appliances and electronics that pose little to no risk for individuals
with cardiac pacemakers. They should be kept at least six inches away from a pacemaker.
In this study participants will wear the activity monitor on their right hip, therefore it will
be worn more than six inches away from a pacemaker.
b) A risk of participating in this study is a loss of confidentiality. To reduce the risk of this
violation, each participant will be assigned a number. Only the PI will know the number
associated with each participant. All signed informed consent documents and data sheets
will be stored in separate locked file cabinets. Informed consent documents will be store
in a locked file cabinet in the Applied Physiology Laboratory in the Health, Physical
Education, and Recreation Building in room 317. All data sheets will be stored in a locked
file cabinet in the Applied Physiology Laboratory in the Health, Physical Education, and
Recreation Building in room 303. Informed consent documents and data sheets will be
kept for three (3) years after the study has been completed.
Are there benefits to taking part in the study?
The potential benefits to you include.
a) The possible benefits to society may improve scientific knowledge concerning the
relationships between state-anxiety, core affect, fatigue, self-efficacy, and intentions as
they relate to physical activity during phase II cardiac rehabilitation. This information
may be used to guide future cardiac rehabilitation interventions better promote continued
attendance and participation.
Initials of Consentee
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If you do not choose to take part in this study, you will complete phase II cardiac rehabilitation
as ordered by your physician.

How many people will be in the study?
About 30 people will be in this study at UT Medical Center (UTMC).
What will it cost me to be in the study?
There are no costs to you or your insurance for taking part in this study.
Will I be paid for taking part?
You will not be paid for taking part in this study.
Is the Investigator paid to do this study?
No, the investigator is not being paid to enroll people in this study.
What if I am injured in this study?
You will get medical treatment if you are injured as a result of taking part in this study. You
and/or your health plan will be charged for this treatment. The study will not pay for medical
treatment.
It is important that you tell your study leader, Lindsay Toth, if you feel that you have been injured
because of taking part in this study. You can tell her in person or call her at 412600-4342. You
may also tell your doctor if you feel you have been injured because of taking part in this study.
You are not waiving any legal rights or releasing the University of Tennessee or its agents from
liability for negligence. In the event of physical injury resulting from research procedures the
University of Tennessee does not have funds budgeted for compensation either for lost wages
or for medical treatment.
In the case of injury resulting from this study, you do not lose any of your legal rights to seek
payment by signing this form.
Who do I call if I have questions about the study?
Questions about the study:
Lindsay Toth,
M.S.
Phone: 412600-4342
Email: Ltoth2@v ols.utk.edu
Initials of Consentee
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Questions about your rights as a research subject: You may contact the UT Graduate School of
Medicine Institutional Review Board (IRB) at 865-305-9781. The IRB is a group of people that
reviews studies for safety and to protect the rights of study subjects.
Can I stop being in the study?
You may withdraw from the study at any time. Your treatment, payment or enrollment in any
health plans or eligibility for benefits will not be affected if you decide not to take part.
Could I be removed from the study?
You may be withdrawn for the study for any of the following reasons:
▪ Survey compliance rates fall below 50%
▪ You are unable to respond to the mobile surveys
Identifiable private information or identifiable biospecimens:
Identifiers might be removed from the identifiable private information and after such removal, the
information could be used for future research studies or distributed to another investigator for
future research studies without additional informed consent from you or your legally authorized
representative.
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CONSENT OF SUBJECT:
I have read or have had read to me the description of the research study. The investigator or
his/her representative has explained the study to me and has answered all of the questions I have
at this time. I have been told of the potential risks, discomforts and side effects as well as the
possible benefits (if any) of the study. I will receive a copy of this form after it is signed.
I freely volunteer to take part in this study.

Printed Name of Subject

Signature of Subject or
Authorized
Representative

Date & Time

Printed name of person
Obtaining Consent

Signature of person
Obtaining Consent

Date

Printed name of Investigator

Signature of Investigator

Date
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